title,url,time_published,summary,ticker,relevance_score,ticker_sentiment_score,ticker_sentiment_label
This week will make it clearer if the Fed will cut interest rates in March | Business,https://www.cnn.com/2024/01/28/business/stocks-week-ahead-economic-data-march-cut-fed/index.html,2024-01-28 12:30:00,This week will make it clearer if the Fed will cut interest rates in March ...,DGX,0.023169,-0.021795,Neutral
Quest Diagnostics  ( DGX )  Advances in Cancer Research With New Deal,https://www.zacks.com/stock/news/2216443/quest-diagnostics-dgx-advances-in-cancer-research-with-new-deal,2024-01-26 14:15:00,Quest Diagnostics' (DGX) subsidiary Haystack Oncology collaborates with TriSalus Life Sciences to improve therapeutic options for aggressive forms of cancer.,DGX,0.15347,0.0,Neutral
"Quest Diagnostics  ( NYSE:DGX )  Upgraded to ""Buy"" by StockNews.com",https://www.defenseworld.net/2024/01/25/quest-diagnostics-nysedgx-upgraded-to-buy-by-stocknews-com.html,2024-01-25 09:54:42,StockNews.com upgraded shares of Quest Diagnostics ( NYSE:DGX - Free Report ) from a hold rating to a buy rating in a research report report published on Wednesday. DGX has been the subject of several other research reports.,DGX,0.858969,0.502968,Bullish
"Anatomic Pathology Market Poised for Remarkable Growth, Anticipating a 8.2% CAGR Leading to US$6.0 Billion Valuation by 2030, Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36740089/anatomic-pathology-market-poised-for-remarkable-growth-anticipating-a-8-2-cagr-leading-to-us-6-0-b,2024-01-23 15:30:00,"New York, Jan. 23, 2024 ( GLOBE NEWSWIRE ) -- The global market for anatomic pathology market is projected to grow at a CAGR of 8.2%, increasing from US$3.5 billion in 2023 to US$6.0 billion by 2030.",DGX,0.020439,0.0,Neutral
Oncology Space Gains Momentum: 3 Stocks in Focus,https://www.zacks.com/stock/news/2214232/oncology-space-gains-momentum-3-stocks-in-focus,2024-01-23 14:50:00,"Stocks such as EXAS, DGX and LH are likely to potentially continue the momentum in the oncology field.",DGX,0.23281,0.255413,Somewhat-Bullish
"New blood test that screens for Alzheimer's may be a step closer to reality, study suggests",https://www.cnn.com/2024/01/22/health/alzheimers-blood-test-screening-study/index.html,2024-01-22 16:00:00,"Testing a person's blood for a type of protein called phosphorylated tau, or p-tau, could be used to screen for Alzheimer's disease with ""high accuracy,"" even before symptoms begin to show, a new study suggests.",DGX,0.023079,0.024464,Neutral
3 Discounted MedTech Stocks Poised for Sturdy Growth in 2024,https://www.zacks.com/stock/news/2212910/3-discounted-medtech-stocks-poised-for-sturdy-growth-in-2024,2024-01-19 16:21:00,"Prestige Consumer Health (PBH), Quest Diagnostics (DGX) and Hologic (HOLX) are currently at discounted zone that are expected to provide long-term gains.",DGX,0.139872,0.188322,Somewhat-Bullish
Quest Diagnostics  ( DGX )  and Fitbit Team Up for New Pilot Study,https://www.zacks.com/stock/news/2212626/quest-diagnostics-dgx-and-fitbit-team-up-for-new-pilot-study,2024-01-19 12:25:00,Quest Diagnostics (DGX) partners with Fitbit to study the potential of wearable devices to improve metabolic health.,DGX,0.362725,0.292105,Somewhat-Bullish
Quest Diagnostics  ( DGX )  to Post Q4 Earnings: What's in Store?,https://www.zacks.com/stock/news/2211906/quest-diagnostics-dgx-to-post-q4-earnings-whats-in-store,2024-01-18 12:18:00,Quest Diagnostics' (DGX) fourth-quarter 2023 results are likely to reflect the robust strength of its base business.,DGX,0.544099,0.30164,Somewhat-Bullish
Quest Diagnostics  ( DGX )  Inks New Deal With Ultima Genomics,https://www.zacks.com/stock/news/2209990/quest-diagnostics-dgx-inks-new-deal-with-ultima-genomics,2024-01-15 12:46:00,Quest Diagnostics' (DGX) new partnership is likely to leverage its oncology expertise and national scale.,DGX,0.361407,0.031225,Neutral
Evolving Landscape For Alzheimer's Blood Tests Gains Momentum Amid Inaccuracy Concerns - Biogen  ( NASDAQ:BIIB ) ,https://www.benzinga.com/news/24/01/36615264/evolving-landscape-for-alzheimers-blood-tests-gains-momentum-amid-inaccuracy-concerns,2024-01-12 18:17:14,"A new era in Alzheimer's diagnosis is on the horizon as Dr. Suzanne Schindler and her team at Washington University School of Medicine pioneered blood tests capable of detecting sticky amyloid plaques, a key Alzheimer's indicator.",DGX,0.155954,0.096036,Neutral
Is Quest Diagnostics  ( DGX )  Stock Undervalued Right Now?,https://www.zacks.com/stock/news/2208254/is-quest-diagnostics-dgx-stock-undervalued-right-now,2024-01-10 14:40:11,"Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",DGX,0.48028,0.462154,Bullish
Quest Diagnostics  ( DGX )  to Boost Lab Services With New Buyout,https://www.zacks.com/stock/news/2207650/quest-diagnostics-dgx-to-boost-lab-services-with-new-buyout,2024-01-09 18:01:00,"Quest Diagnostics' (DGX) recent acquisition seeks to increase accessibility to cutting-edge, high-caliber and reasonably priced laboratory services.",DGX,0.626755,0.496531,Bullish
Quest Diagnostics Acquires Select Assets of Outreach Lab Services Business of Steward Health Care System,https://www.prnewswire.com/news-releases/quest-diagnostics-acquires-select-assets-of-outreach-lab-services-business-of-steward-health-care-system-302027805.html,2024-01-08 13:56:00,"Transaction to broaden access to innovative, quality diagnostic information services for providers and patients",DGX,0.265378,0.391599,Bullish
Reasons to Retain Quest Diagnostics  ( DGX )  Stock for Now,https://www.zacks.com/stock/news/2205238/reasons-to-retain-quest-diagnostics-dgx-stock-for-now,2024-01-03 18:45:00,Investors are optimistic about Quest Diagnostics (DGX) on strength in base business and strategic collaborations.,DGX,0.410059,0.367643,Bullish
"EarlyDiagnostics, Inc. Appoints Gregory C. Critchfield, M.D. M.S., as Co-CEO",https://www.prnewswire.com/news-releases/earlydiagnostics-inc-appoints-gregory-c-critchfield-md-ms-as-co-ceo-302025005.html,2024-01-03 14:00:00,Highly accomplished industry executive joins company to help drive forward its world-class early cancer detection liquid biopsy testing,DGX,0.05339,0.001998,Neutral
"Quest Diagnostics  ( NYSE:DGX )  Cut to ""Hold"" at StockNews.com",https://www.defenseworld.net/2024/01/03/quest-diagnostics-nysedgx-cut-to-hold-at-stocknews-com.html,2024-01-03 06:12:46,"Quest Diagnostics ( NYSE:DGX - Get Free Report ) was downgraded by equities researchers at StockNews.com from a ""buy"" rating to a ""hold"" rating in a research report issued to clients and investors on Wednesday. DGX has been the topic of several other reports.",DGX,0.864442,0.491476,Bullish
Here's Why Investors Should Retain Labcorp  ( LH )  Stock for Now,https://www.zacks.com/stock/news/2203637/heres-why-investors-should-retain-labcorp-lh-stock-for-now,2023-12-29 14:23:00,Investors remain optimistic about Labcorp (LH) due to impressive partnerships and expansion efforts in targeted high-growth areas.,DGX,0.042571,0.123427,Neutral
Quest Diagnostics  ( NYSE:DGX )  Rating Increased to Buy at StockNews.com,https://www.defenseworld.net/2023/12/26/quest-diagnostics-nysedgx-rating-increased-to-buy-at-stocknews-com.html,2023-12-26 06:18:46,"Quest Diagnostics ( NYSE:DGX - Get Free Report ) was upgraded by analysts at StockNews.com from a ""hold"" rating to a ""buy"" rating in a research note issued on Tuesday. A number of other analysts have also commented on the company.",DGX,0.849046,0.392964,Bullish
Quest Diagnostics Gains Momentum: Analyst Highlights Strong Business Trends And Growth Opportunities - Quest Diagnostics  ( NYSE:DGX ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/12/36330937/quest-diagnostics-gains-momentum-analyst-highlights-strong-business-trends-and-grow,2023-12-20 19:14:23,"Truist Securities analyst David S. MacDonald reiterated a Hold rating on Quest Diagnostics Incorporated DGX, raising the price target to $150 from $145. MacDonald bumped the price target following management meetings focused on strong base business trends, areas of growth opportunity, ongoing ...",DGX,0.483434,0.453532,Bullish
Quest Diagnostics  ( DGX )  Unveils the 88-Compound NPS Test Panel,https://www.zacks.com/stock/news/2200390/quest-diagnostics-dgx-unveils-the-88-compound-nps-test-panel,2023-12-20 12:01:00,Quest Diagnostics (DGX) launches the new 88-Compound NPS test panel to address the changing drug epidemic.,DGX,0.395705,-0.093476,Neutral
Quest Diagnostics'  ( DGX )  Haystack Oncology Inks New Deal,https://www.zacks.com/stock/news/2199231/quest-diagnostics-dgx-haystack-oncology-inks-new-deal,2023-12-18 12:47:00,"Quest Diagnostics' (DGX) wholly owned subsidiary, Haystack Oncology, partners with the Rutgers Cancer Institute of New Jersey.",DGX,0.449106,-0.018219,Neutral
Quest Diagnostics  ( NYSE:DGX )  Raised to Buy at StockNews.com,https://www.defenseworld.net/2023/12/17/quest-diagnostics-nysedgx-raised-to-buy-at-stocknews-com.html,2023-12-17 06:56:43,StockNews.com upgraded shares of Quest Diagnostics ( NYSE:DGX - Free Report ) from a hold rating to a buy rating in a research report sent to investors on Friday.,DGX,0.857622,0.400947,Bullish
"Quest Diagnostics  ( NYSE:DGX )  Upgraded to ""Buy"" by StockNews.com",https://www.defenseworld.net/2023/12/17/quest-diagnostics-nysedgx-upgraded-to-buy-by-stocknews-com.html,2023-12-17 06:56:42,"Quest Diagnostics ( NYSE:DGX - Get Free Report ) was upgraded by equities researchers at StockNews.com from a ""hold"" rating to a ""buy"" rating in a research note issued on Friday.",DGX,0.879609,0.351122,Bullish
"Beat the Market the Zacks Way: Shopify, Lululemon, Telos in Focus",https://www.zacks.com/stock/news/2195999/beat-the-market-the-zacks-way-shopify-lululemon-telos-in-focus,2023-12-11 12:56:00,Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.,DGX,0.069697,0.061417,Neutral
Quest Diagnostics  ( DGX )  & CDC to Assess Hepatitis C Burden,https://www.zacks.com/stock/news/2195277/quest-diagnostics-dgx-cdc-to-assess-hepatitis-c-burden,2023-12-08 12:25:00,Quest Diagnostics (DGX) and CDC expand research collaboration to better understand the Hepatitis C burden in the United States.,DGX,0.62148,0.255827,Somewhat-Bullish
DaVita HealthCare  ( DVA )  Up 22.8% Since Last Earnings Report: Can It Continue?,https://www.zacks.com/stock/news/2194943/davita-healthcare-dva-up-228-since-last-earnings-report-can-it-continue,2023-12-07 16:31:01,DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,DGX,0.216376,0.024913,Neutral
Quest Diagnostics and CDC Expand Public Health Research Collaboration to Better Understand Hepatitis C Burden in the United States - Quest Diagnostics  ( NYSE:DGX ) ,https://www.benzinga.com/pressreleases/23/12/n36131762/quest-diagnostics-and-cdc-expand-public-health-research-collaboration-to-better-understand-hepatit,2023-12-07 13:01:00,"Quest will provide research consulting, laboratory testing and data analytics services to generate diagnostics insights supporting population health strategy for hepatitis C",DGX,0.326643,0.294558,Somewhat-Bullish
"Biomarkers Market size to grow by USD 56.26 billion from 2022 to 2027| Abbott Laboratories, Abcam plc, Agilent ... - PR Newswire",https://www.prnewswire.com/news-releases/biomarkers-market-size-to-grow-by-usd-56-26-billion-from-2022-to-2027-abbott-laboratories-abcam-plc-agilent-technologies-inc-and-more-among-the-key-companies-in-the-market---technavio-302004841.html,2023-12-05 01:30:00,"Biomarkers Market size to grow by USD 56.26 billion from 2022 to 2027| Abbott Laboratories, Abcam plc, Agilent ... PR ...",DGX,0.07913,-0.019424,Neutral
In-vitro Diagnostics Market to grow by USD 33.16 billion from 2021 to 2026| The rising geriatric population with chronic ... - PR Newswire,https://www.prnewswire.com/news-releases/in-vitro-diagnostics-market-to-grow-by-usd-33-16-billion--from-2021-to-2026-the-rising-geriatric-population-with-chronic-and-infectious-diseases-drives-the-market-growth--technavio-302003823.html,2023-12-04 03:20:00,In-vitro Diagnostics Market to grow by USD 33.16 billion from 2021 to 2026| The rising geriatric population with chronic ... PR ...,DGX,0.062926,0.148111,Neutral
Reasons to Retain Quest Diagnostics  ( DGX )  Stock for Now,https://www.zacks.com/stock/news/2191302/reasons-to-retain-quest-diagnostics-dgx-stock-for-now,2023-11-30 12:28:00,Investors are optimistic about Quest Diagnostics (DGX) on the strength of the base business.,DGX,0.379435,0.455406,Bullish
Quest Diagnostics'  ( DGX )  New Pact to Scale Precision Medicine,https://www.zacks.com/stock/news/2191001/quest-diagnostics-dgx-new-pact-to-scale-precision-medicine,2023-11-29 16:33:00,Quest Diagnostics' (DGX) will supply next-generation sequencing and enhanced RNA extraction services for Scipher's PrismRA test through a new collaboration.,DGX,0.614479,0.317989,Somewhat-Bullish
Here's Why Investors Should Retain Labcorp  ( LH )  Stock for Now,https://www.zacks.com/stock/news/2189584/heres-why-investors-should-retain-labcorp-lh-stock-for-now,2023-11-27 13:35:00,Investors are increasingly optimistic about Labcorp (LH) due to development in targeted high-growth areas.,DGX,0.042196,0.123309,Neutral
Blockchain and data privacy: Safeguarding patient information in the digital age,https://www.financialexpress.com/business/digital-transformation-blockchain-and-data-privacy-safeguarding-patient-information-in-the-digital-age-3318196/,2023-11-26 11:51:00,"In the digital age, the healthcare industry is heavily reliant on technology for data management. However, this shift has raised significant concerns about data privacy, particularly when it comes to safeguarding patient information.",DGX,0.04583,-0.008985,Neutral
"Quest Diagnostics  ( NYSE:DGX )  Upgraded by StockNews.com to ""Buy""",https://www.defenseworld.net/2023/11/25/quest-diagnostics-nysedgx-upgraded-by-stocknews-com-to-buy-2.html,2023-11-25 08:58:47,StockNews.com upgraded shares of Quest Diagnostics ( NYSE:DGX - Free Report ) from a hold rating to a buy rating in a research report sent to investors on Friday. Other equities analysts have also recently issued research reports about the stock.,DGX,0.81111,0.458319,Bullish
Quest Diagnostics  ( DGX )  Up 8.2% Since Last Earnings Report: Can It Continue?,https://www.zacks.com/stock/news/2188562/quest-diagnostics-dgx-up-82-since-last-earnings-report-can-it-continue,2023-11-23 16:30:54,Quest Diagnostics (DGX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,DGX,0.390904,0.138872,Neutral
InnovationRx: Generative AI For Drug Discovery,https://www.forbes.com/sites/alexknapp/2023/11/22/innovationrx-generative-ai-for-drug-discovery/,2023-11-22 19:22:03,"InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here. On Tuesday, Roche subsidiary Genentech announced that it's entered into a multi-year research collaboration with Nvidia.",DGX,0.128822,-0.084452,Neutral
Population Screening Market Is Expected To Reach $35.3 Billion By 2027 With The Rising Prevalence Of Cancer As Per The Business Research Company's Population Screening Global Market Report 2023,https://www.benzinga.com/pressreleases/23/11/g35920043/population-screening-market-is-expected-to-reach-35-3-billion-by-2027-with-the-rising-prevalence-o,2023-11-22 16:30:00,"LONDON, Nov. 22, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Population Screening Global Market Report 2023, the global population screening market is gearing up for substantial growth, set to rise from $25.04 billion in 2022 to $27.02 billion in 2023, showcasing a ...",DGX,0.058188,0.147997,Neutral
Quest Diagnostics'  ( DGX )  New Pact to Advance Cancer Screening,https://www.zacks.com/stock/news/2187944/quest-diagnostics-dgx-new-pact-to-advance-cancer-screening,2023-11-22 15:38:00,"Quest Diagnostics' (DGX) latest partnership will increase the likelihood that Americans will eventually have an easy, reliable and accessible way to check for colorectal cancer.",DGX,0.511864,0.210453,Somewhat-Bullish
Universal DX Announces Strategic Collaboration with Quest Diagnostics to Bring Advanced Colorectal Cancer Screening Blood Test to Patients and Providers in the United States,https://www.prnewswire.com/news-releases/universal-dx-announces-strategic-collaboration-with-quest-diagnostics-to-bring-advanced-colorectal-cancer-screening-blood-test-to-patients-and-providers-in-the-united-states-301993569.html,2023-11-20 13:52:00,Universal DX Announces Strategic Collaboration with Quest Diagnostics to Bring Advanced Colorectal Cancer ... PR ...,DGX,0.291347,0.139576,Neutral
"StockNews.com Upgrades Quest Diagnostics  ( NYSE:DGX )  to ""Buy""",https://www.defenseworld.net/2023/11/17/stocknews-com-upgrades-quest-diagnostics-nysedgx-to-buy.html,2023-11-17 08:32:53,"Quest Diagnostics ( NYSE:DGX - Get Free Report ) was upgraded by equities researchers at StockNews.com from a ""hold"" rating to a ""buy"" rating in a note issued to investors on Wednesday. A number of other equities analysts have also recently issued reports on the company.",DGX,0.816044,0.457808,Bullish
Quest Diagnostics  ( DGX )  Introduces Mobile Phlebotomy Service,https://www.zacks.com/stock/news/2183411/quest-diagnostics-dgx-introduces-mobile-phlebotomy-service,2023-11-13 15:34:00,Quest Diagnostics (DGX) can offer patients and physicians a seamless connection to Quest Diagnostic's laboratory testing with the launch of Quest Mobile.,DGX,0.5174,0.40802,Bullish
Firing on All Cylinders Indeed,https://www.fool.com/investing/2023/11/11/firing-on-all-cylinders-indeed/,2023-11-11 12:00:00,Investors are seeing some big reactions to earnings results in tech and have a few reasons to think some beaten-up names might be finding their footing.,DGX,0.020062,0.109862,Neutral
Rutgers MBA enabled student to think about business on a higher level,https://www.prnewswire.com/news-releases/rutgers-mba-enabled-student-to-think-about-business-on-a-higher-level-301977226.html,2023-11-08 15:05:00,"""I really wanted to experience everything the MBA had to offer, so I was willing to put myself out there,"" said Felli, who concentrated his studies in finance and entrepreneurship. ""It was pretty tough because we had a late start. It was probably because of the challenges that made us dig deep ...",DGX,0.146469,0.095235,Neutral
"Corporate Wellness Market size to grow by USD 29.20 billion from 2022 to 2027 | Aduro LLC, Central Corporate ... - PR Newswire",https://www.prnewswire.com/news-releases/corporate-wellness-market-size-to-grow-by-usd-29-20-billion-from-2022-to-2027--aduro-llc-central-corporate-wellness-compsych-corp-and-more-among-the-key-companies-in-the-market---technavio-301976413.html,2023-11-03 02:35:00,"Corporate Wellness Market size to grow by USD 29.20 billion from 2022 to 2027 | Aduro LLC, Central Corporate ... PR ...",DGX,0.041251,0.221359,Somewhat-Bullish
Ovarian Cancer Treatment Market To Reach USD 18.3 Billion By 2031. By TMR,https://www.benzinga.com/pressreleases/23/11/g35564549/ovarian-cancer-treatment-market-to-reach-usd-18-3-billion-by-2031-by-tmr,2023-11-02 14:00:00,"Wilmington, Delaware, United States, Nov. 02, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global ovarian cancer treatment market was estimated to have acquired US$ 5.1 billion in 2022. It is anticipated to register a 15.4% CAGR from 2023 to 2031 and by 2031, the market is ...",DGX,0.042876,0.085974,Neutral
Quest Diagnostics  ( NYSE:DGX )  Stock Rating Lowered by StockNews.com,https://www.defenseworld.net/2023/11/02/quest-diagnostics-nysedgx-stock-rating-lowered-by-stocknews-com.html,2023-11-02 07:16:42,Quest Diagnostics ( NYSE:DGX ) Stock Rating Lowered by ... Defense World ...,DGX,0.870266,0.44666,Bullish
RAPIDLY GROWING JARRARD INC. APPOINTS NEW VP OF STRATEGIC PARTNERSHIPS,https://www.prnewswire.com/news-releases/rapidly-growing-jarrard-inc-appoints-new-vp-of-strategic-partnerships-301970523.html,2023-10-27 20:05:00,"BRENTWOOD, Tenn. and CHICAGO, Oct. 27, 2023 /PRNewswire/ -- National healthcare strategic communications advisory firm Jarrard Inc. has added five new professionals to its team, including veteran business development expert Jennifer Dye as vice president of strategic partnerships, supporting the ...",DGX,0.060388,0.075,Neutral
Molina Healthcare  ( MOH )  Q3 Earnings Beat on Membership Growth,https://www.zacks.com/stock/news/2173103/molina-healthcare-moh-q3-earnings-beat-on-membership-growth,2023-10-26 16:40:00,Molina Healthcare's (MOH) third-quarter results gain from changes in the member mix and a growing premium base. Management reiterates its 2023 adjusted EPS guidance to be a minimum of $20.75.,DGX,0.124593,-0.027836,Neutral
Labcorp beats quarterly profit estimates on strength in routine testing segment,https://www.reuters.com/business/healthcare-pharmaceuticals/labcorp-beats-quarterly-profit-estimates-strength-routine-testing-segment-2023-10-26/,2023-10-26 12:08:00,"The logo for Labcorp, Laboratory Corporation of America, a life sciences company is displayed on a screen on the floor of the New York Stock Exchange ( NYSE ) in New York City, U.S., June 22, 2023. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights",DGX,0.13459,-0.077488,Neutral
Quest Diagnostics  ( NYSE:DGX )  Upgraded by StockNews.com to Buy,https://www.defenseworld.net/2023/10/26/quest-diagnostics-nysedgx-upgraded-by-stocknews-com-to-buy.html,2023-10-26 09:00:41,StockNews.com upgraded shares of Quest Diagnostics ( NYSE:DGX - Free Report ) from a hold rating to a buy rating in a report released on Wednesday morning. DGX has been the subject of a number of other reports. TheStreet cut Quest Diagnostics from a b- rating to a c rating in a research report ...,DGX,0.819113,0.43641,Bullish
Teladoc Health  ( TDOC )  Q3 Loss Narrows on Integrated Care Strength,https://www.zacks.com/stock/news/2171950/teladoc-health-tdoc-q3-loss-narrows-on-integrated-care-strength,2023-10-25 15:42:00,Teladoc Health's (TDOC) Q3 results were aided by membership growth in the Integrated Care unit as well as strong BetterHelp revenues. Management presently expects 2023 net loss per share to be within $1.50-$1.40.,DGX,0.094762,0.015913,Neutral
"Quest Diagnostics  ( DGX )  Tops Q3 Earnings, Gross Margin Dips",https://www.zacks.com/stock/news/2170976/quest-diagnostics-dgx-tops-q3-earnings-gross-margin-dips,2023-10-24 15:42:00,"Quest Diagnostics' (DGX) base business growth reflects the company's ongoing efforts to partner with health plans, hospitals and physicians amid a continued return to care.",DGX,0.412861,-0.134865,Neutral
"Quest Diagnostics Q3: 7.7% Topline Decline, Earnings Beat, Updated Guidance & More - Quest Diagnostics  ( NYSE:DGX ) ",https://www.benzinga.com/news/earnings/23/10/35395545/quest-diagnostics-q3-7-7-topline-decline-earnings-beat-updated-guidance-more,2023-10-24 14:38:22,"Quest Diagnostics Incorporated DGX posted Q3 FY23 adjusted EPS of $2.22, down 5.9% Y/Y, beating the consensus of $2.19. Sales came in at $2.295 billion, a decline of 7.7% Y/Y, higher than the Wall Street estimate of $2.27 billion.",DGX,0.633079,0.193987,Somewhat-Bullish
Quest raises annual forecast as routine testing recovery powers quarterly beat,https://www.reuters.com/business/healthcare-pharmaceuticals/quest-raises-annual-forecast-routine-testing-recovery-powers-quarterly-beat-2023-10-24/,2023-10-24 12:33:00,"Oct 24 ( Reuters ) - Laboratory operator Quest Diagnostics ( DGX.N ) on Tuesday raised its full-year sales forecast after beating third-quarter expectations for revenue and profit, buoyed by a recovery in routine testing.",DGX,0.165031,0.081453,Neutral
Quest Diagnostics  ( DGX )  Q3 Earnings and Revenues Beat Estimates,https://www.zacks.com/stock/news/2170651/quest-diagnostics-dgx-q3-earnings-and-revenues-beat-estimates,2023-10-24 12:05:04,"Quest Diagnostics (DGX) delivered earnings and revenue surprises of 1.37% and 1.66%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?",DGX,0.390904,0.143143,Neutral
"After a robust third quarter, US economic growth will likely slow. That bodes well for rate cuts next year. | Business",https://www.cnn.com/2023/10/22/economy/stocks-week-ahead-q3-gdp/index.html,2023-10-22 12:04:00,"After a robust third quarter, US economic growth will likely slow. That bodes well for rate cuts next year. ...",DGX,0.032207,0.0,Neutral
Invitae Appoints Dr. David Sholehvar as Chief Operating Officer,https://www.prnewswire.com/news-releases/invitae-appoints-dr-david-sholehvar-as-chief-operating-officer-301962415.html,2023-10-19 20:30:00,"SAN FRANCISCO, Oct. 19, 2023 /PRNewswire/ -- ( NYSE: NVTA ) , a leading medical genetics company, today announced the appointment of veteran healthcare leader David Sholehvar, M.D., as chief operating officer, effective November 13, 2023.",DGX,0.046907,0.006971,Neutral
Encompass Health  ( EHC )  Reports Next Week: Wall Street Expects Earnings Growth,https://www.zacks.com/stock/news/2168942/encompass-health-ehc-reports-next-week-wall-street-expects-earnings-growth,2023-10-19 14:01:38,Encompass Health (EHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,DGX,0.173022,-0.002826,Neutral
Quest Diagnostics  ( DGX )  to Post Q3 Earnings: What's in Store?,https://www.zacks.com/stock/news/2168634/quest-diagnostics-dgx-to-post-q3-earnings-whats-in-store,2023-10-19 12:32:00,Quest Diagnostics (DGX) third-quarter 2023 results are likely to reflect continued strength in the base business.,DGX,0.538084,0.425357,Bullish
Quest Diagnostics  ( DGX )  Gains From New Alliances Amid FX Woes,https://www.zacks.com/stock/news/2168160/quest-diagnostics-dgx-gains-from-new-alliances-amid-fx-woes,2023-10-18 15:10:00,Quest Diagnostics' (DGX) recent acquisition of New York-Presbyterian's outreach assets adds to volume growth within Physician Lab Services.,DGX,0.58463,0.341129,Somewhat-Bullish
Doubts abound about a new Alzheimer's blood test,https://www.cnn.com/2023/10/18/health/alzheimers-blood-test-kff-health-news/index.html,2023-10-18 10:32:00,"For the first time, people worried about their risk of Alzheimer's disease can go online, order a blood test, and receive results in the privacy of their homes. This might seem appealing on the surface, but the development has Alzheimer's researchers and clinicians up in arms.",DGX,0.025514,-0.116428,Neutral
Earnings Preview: Quest Diagnostics  ( DGX )  Q3 Earnings Expected to Decline,https://www.zacks.com/stock/news/2167226/earnings-preview-quest-diagnostics-dgx-q3-earnings-expected-to-decline,2023-10-17 14:00:56,Quest Diagnostics (DGX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,DGX,0.295273,-0.017694,Neutral
QUEST DIAGNOSTICS WORKERS IN GEORGIA JOIN TEAMSTERS,https://www.prnewswire.com/news-releases/quest-diagnostics-workers-in-georgia-join-teamsters-301956603.html,2023-10-13 20:31:00,"TUCKER, Ga., Oct. 13, 2023 /PRNewswire/ -- Route service representatives at Quest Diagnostics in Tucker have voted to join Teamsters Local 728.",DGX,0.612033,0.764257,Bullish
"Is There A Blood Test for Alzheimer's? Progress Underway, But Not Quite Ready - Roche Holding  ( OTC:RHHBF ) , Roche Holding  ( OTC:RHHVF ) , Roche Holding  ( OTC:RHHBY ) ",https://www.benzinga.com/news/large-cap/23/10/35199963/is-there-a-blood-test-for-alzheimers-progress-underway-but-not-quite-ready,2023-10-11 18:27:04,"Blood tests for diagnosing Alzheimer's disease are eagerly awaited, but it may be a couple of years before they become a routine diagnostic tool. While several blood tests for Alzheimer's diagnosis are in development, none are approved by regulators or insurance reimbursement.",DGX,0.229149,-0.012987,Neutral
Blood tests needed for widespread Alzheimer's diagnosis on the way,https://www.reuters.com/business/healthcare-pharmaceuticals/blood-tests-needed-widespread-alzheimers-diagnosis-way-2023-10-11/,2023-10-11 11:36:00,"[1/3] A view shows tests for patients suffering from Alzheimer's disease at the Memory Centre Department of Readaptation and Geriatrics of the University Hospital ( HUG ) , in Geneva, Switzerland, June 6, 2023. REUTERS/Denis Balibouse/File Photo Acquire Licensing Rights",DGX,0.044469,-0.04557,Neutral
"Global Hereditary Testing Market Shows Strong 8.8% CAGR, Driving Demand for Hereditary Disorder Testing Kits",https://www.benzinga.com/pressreleases/23/10/g35168974/global-hereditary-testing-market-shows-strong-8-8-cagr-driving-demand-for-hereditary-disorder-test,2023-10-10 18:15:00,"New York, United States, Oct. 10, 2023 ( GLOBE NEWSWIRE ) -- Hereditary genes are either transmitted to offspring or inheritable from parents. Hereditary testing examines an individual's genome for specific hereditary variations ( variants ) .",DGX,0.03804,0.0,Neutral
Quest Diagnostics  ( DGX )  to Boost Lab Services With New Pact,https://www.zacks.com/stock/news/2161745/quest-diagnostics-dgx-to-boost-lab-services-with-new-pact,2023-10-06 15:33:00,Quest Diagnostics (DGX) latest deal will boost dialysis laboratory testing and reduce the laboratory costs of dialysis programs for ESRD patients.,DGX,0.653822,0.347787,Somewhat-Bullish
Are Penny Stocks Worth It? 4 To Watch With Big News,https://pennystocks.com/featured/2023/10/04/are-penny-stocks-worth-it-4-to-watch-with-big-news/,2023-10-04 18:10:36,"The Effect of News on Penny Stocks and Building a Watchlist Penny stocks, defined as stocks trading under $5 per share, are known for their volatility and potential for significant returns. However, the low price of these stocks also makes them susceptible to dramatic price swings based on ...",DGX,0.028524,0.0,Neutral
Should Value Investors Buy Quest Diagnostics  ( DGX )  Stock?,https://www.zacks.com/stock/news/2158693/should-value-investors-buy-quest-diagnostics-dgx-stock,2023-10-02 13:40:11,"Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",DGX,0.52706,0.206415,Somewhat-Bullish
FDA wants to regulate thousands of lab tests that have long skirted oversight,https://apnews.com/article/laboratory-tests-medical-fda-theranos-ef8794541b5237f8d2b54fe070d596ce,2023-09-29 16:38:00,"WASHINGTON ( AP ) - The Food and Drug Administration on Friday laid out a proposal to begin regulating laboratory medical tests, a multibillion-dollar industry that the agency says poses a growing risk to patients because of potentially inaccurate results.",DGX,0.044718,-0.049996,Neutral
Here's Why Investors Should Retain Labcorp  ( LH )  Stock for Now,https://www.zacks.com/stock/news/2157001/heres-why-investors-should-retain-labcorp-lh-stock-for-now,2023-09-28 13:06:00,Investors are increasingly optimistic about Labcorp (LH) due to its progress in hospital partnerships.,DGX,0.043818,0.1238,Neutral
Biopsy Market to grow at a CAGR of 11.14% during the forecast period reaching USD 61.03 Bn. by 2029 - says Maximize Market Research,https://www.benzinga.com/pressreleases/23/09/g34788934/biopsy-market-to-grow-at-a-cagr-of-11-14-during-the-forecast-period-reaching-usd-61-03-bn-by-2029-,2023-09-21 11:41:19,"Pune, Sept. 21, 2023 ( GLOBE NEWSWIRE ) -- A global healthcare business-consulting firm, Maximize Market Research, has published a market intelligence and competitive landscape report on the ""Biopsy Market"".",DGX,0.029618,0.028382,Neutral
Reasons to Retain Quest Diagnostics  ( DGX )  Stock for Now,https://www.zacks.com/stock/news/2153212/reasons-to-retain-quest-diagnostics-dgx-stock-for-now,2023-09-20 14:40:00,"Investors are optimistic about Quest Diagnostics (DGX), backed by collaborations with health plans and upbeat guidance.",DGX,0.522096,0.230847,Somewhat-Bullish
"Zacks Industry Outlook Highlights P3 Health Partners, Talkspace and Augmedix",https://www.zacks.com/stock/news/2152934/zacks-industry-outlook-highlights-p3-health-partners-talkspace-and-augmedix,2023-09-20 11:22:00,"P3 Health Partners, Talkspace and Augmedix are pat of the Zacks Industry Outlook article.",DGX,0.029691,0.091163,Neutral
3 Medical Info Systems Stocks to Buy as Industry Trends Improve,https://www.zacks.com/commentary/2152418/3-medical-info-systems-stocks-to-buy-as-industry-trends-improve,2023-09-19 14:04:00,"Zacks Medical Info Systems industry stocks like P3 Health Partners (PIII), Talkspace (TALK) and Augmedix (AUGX) are expected to gain from the new normal trends.",DGX,0.030641,0.108867,Neutral
Neurological Biomarkers Market to grow by USD 6.92 billion from 2022 to 2027 | North America to account for 43% of ... - PR Newswire,https://www.prnewswire.com/news-releases/neurological-biomarkers-market-to-grow-by-usd-6-92-billion-from-2022-to-2027--north-america-to-account-for-43-of-market-growth--technavio-301929311.html,2023-09-18 05:35:00,Neurological Biomarkers Market to grow by USD 6.92 billion from 2022 to 2027 | North America to account for 43% of ... PR ...,DGX,0.056808,0.044936,Neutral
Quest Diagnostics  ( DGX )  to Aid Health Equity With New Pact,https://www.zacks.com/stock/news/2149077/quest-diagnostics-dgx-to-aid-health-equity-with-new-pact,2023-09-14 15:38:00,Quest Diagnostics (DGX) and Americares will provide 10 clinics with no-cost diagnostic services for a year to help patients manage chronic disease.,DGX,0.420705,0.325689,Somewhat-Bullish
"COVID-19 Diagnostics Market Revenue to Cross USD 45.8 billion by 2031, Registering a Negative 7.9% CAGR Says, Transparency Market Research",https://www.benzinga.com/pressreleases/23/09/g34527619/covid-19-diagnostics-market-revenue-to-cross-usd-45-8-billion-by-2031-registering-a-negative-7-9-c,2023-09-13 10:20:24,"Wilmington, Delaware, United States, Sept. 13, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The COVID-19 diagnostics market was estimated to have acquired US$ 79.8 billion in 2021. It is anticipated to register a -7.9% CAGR from 2022 to 2031 and by 2031 the market is likely to ...",DGX,0.081138,0.142622,Neutral
"Blood Market to grow by USD 2,195.69 million from 2022 to 2027, North America to account for 40% of market growth ... - PR Newswire",https://www.prnewswire.com/news-releases/blood-market-to-grow-by-usd-2-195-69-million-from-2022-to-2027--north-america-to-account-for-40-of-market-growth---technavio-301921622.html,2023-09-08 23:35:00,"Blood Market to grow by USD 2,195.69 million from 2022 to 2027, North America to account for 40% of market growth ... PR ...",DGX,0.045139,0.118202,Neutral
Quest Diagnostics to Speak at the Baird 2023 Global Healthcare Conference,https://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-the-baird-2023-global-healthcare-conference-301922160.html,2023-09-08 15:38:00,"SECAUCUS, N.J., Sept. 8, 2023 /PRNewswire/ -- Quest Diagnostics Incorporated ( NYSE: DGX ) , the world's leading provider of diagnostic information services, announced that Sam Samad, Executive Vice President and Chief Financial Officer, will speak on the company's strategy, performance and the ...",DGX,0.518022,0.478861,Bullish
"Direct to Consumer Laboratory Testing Market to grow by USD 9.70 billion from 2022 to 2027, North America to ... - PR Newswire",https://www.prnewswire.com/news-releases/direct-to-consumer-laboratory-testing-market-to-grow-by-usd-9-70-billion-from-2022-to-2027--north-america-to-account-for-39-of-market-growth--technavio-301917037.html,2023-09-05 10:00:00,"Direct to Consumer Laboratory Testing Market to grow by USD 9.70 billion from 2022 to 2027, North America to ... PR ...",DGX,0.054114,0.0,Neutral
Quest Diagnostics'  ( DGX )  AAV Test Gets FDA's Breakthrough Nod,https://www.zacks.com/stock/news/2143415/quest-diagnostics-dgx-aav-test-gets-fdas-breakthrough-nod,2023-09-01 11:18:00,Quest Diagnostics (DGX) achieves breakthrough designation for AAVrh74 ELISA and expands collaboration with Sarepta Therapeutics.,DGX,0.450496,0.279689,Somewhat-Bullish
"Verizon extends partnership with MetLife Stadium, New York Jets, New York Giants",https://www.globenewswire.com/news-release/2023/08/31/2735417/0/en/Verizon-extends-partnership-with-MetLife-Stadium-New-York-Jets-New-York-Giants.html,2023-08-31 14:00:00,Renewal includes major Verizon network upgrade for MetLife Stadium Renewal includes major Verizon network upgrade for MetLife Stadium ...,DGX,0.028288,0.198802,Somewhat-Bullish
"Verizon extends partnership with MetLife Stadium, New York Jets, New York Giants - Verizon Communications  ( NYSE:VZ ) ",https://www.benzinga.com/pressreleases/23/08/g34145039/verizon-extends-partnership-with-metlife-stadium-new-york-jets-new-york-giants,2023-08-31 14:00:00,"EAST RUTHERFORD, N.J. , Aug. 31, 2023 ( GLOBE NEWSWIRE ) -- Today, Verizon announced a deal with MetLife Stadium, home of the New York Jets and New York Giants, to provide major network upgrades for 2024 and beyond to accommodate the exponential increase in data customers use during stadium ...",DGX,0.027892,0.198519,Somewhat-Bullish
Invitae Hires Industry Veteran Robert Guigley as Chief Commercial Officer,https://www.prnewswire.com/news-releases/invitae-hires-industry-veteran-robert-guigley-as-chief-commercial-officer-301911496.html,2023-08-28 20:02:00,"- Invitae adds chief commercial officer to leadership team; Innovative leader to help expand market share and drive revenue growth - SAN FRANCISCO, Aug. 28, 2023 /PRNewswire/ -- ( NYSE: NVTA ) , a leading medical genetics company, today announced that it has appointed Robert ( Rob ) Guigley as ...",DGX,0.046273,0.078827,Neutral
"LabCorp  ( LH )  Suffers From Lower COVID Test Sales, Macro Woes",https://www.zacks.com/stock/news/2141387/labcorp-lh-suffers-from-lower-covid-test-sales-macro-woes,2023-08-28 14:40:00,Labcorp's (LH) Early Development Research Laboratories business continues to be constrained by NHP-related supply-chain issues.,DGX,0.068896,0.071218,Neutral
Diagnostics Industry Leader Jack Kenny Joins Biomerica's Board of Directors,https://www.globenewswire.com/news-release/2023/08/28/2732577/0/en/Diagnostics-Industry-Leader-Jack-Kenny-Joins-Biomerica-s-Board-of-Directors.html,2023-08-28 12:19:00,"NEWPORT BEACH, Calif., Aug. 28, 2023 ( GLOBE NEWSWIRE ) -- Biomerica Inc. ( NASDAQ: BMRA ) , a global biomedical company leading the way in innovative gastroenterology solutions, today announced the appointment of Jack Kenny, former CEO and board member of Meridian Bioscience, Inc., to its Board ...",DGX,0.028221,-0.06794,Neutral
Diagnostics Industry Leader Jack Kenny Joins Biomerica's Board of Directors - Biomerica  ( NASDAQ:BMRA ) ,https://www.benzinga.com/pressreleases/23/08/g34066438/diagnostics-industry-leader-jack-kenny-joins-biomericas-board-of-directors,2023-08-28 12:19:00,"Kenny has proven track record of driving growth at companies within the healthcare space and holds significant management and public company board experience, most recently as CEO of Meridian Bioscience As CEO Kenny managed the sale of Meridian Biosciences in an all-cash transaction valued at ...",DGX,0.027828,-0.067794,Neutral
"Toxicology Drug Testing Market Revenue to Cross USD 55.9 billion by 2031, Growing at a CAGR of 5.5% Says Transparency Market Research",https://www.benzinga.com/pressreleases/23/08/g34062809/toxicology-drug-testing-market-revenue-to-cross-usd-55-9-billion-by-2031-growing-at-a-cagr-of-5-5-,2023-08-28 08:17:04,"Wilmington, Delaware, United States, Aug. 28, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global toxicology drug testing market is projected to flourish at a CAGR of 5.5% from 2023 to 2031. As per the report published by TMR, a valuation of US$ 55.9 billion is anticipated ...",DGX,0.040829,0.263355,Somewhat-Bullish
A turbulent few years for stocks has led to a boom in therapy services for stressed out traders,https://africa.businessinsider.com/markets/a-turbulent-few-years-for-stocks-has-led-to-a-boom-in-therapy-services-for-stressed/7ngqz68.amp,2023-08-27 12:15:01,"Her story runs parallel to other full-time traders, either day traders or Wall Street professionals, who have begun flooding the offices of therapists, psychologists, and other mental healthcare providers to sort out feelings of stress after a rollercoaster few years for the stock market.",DGX,0.067536,0.106155,Neutral
A turbulent few years for stocks has led to a boom in therapy services for stressed out traders,https://markets.businessinsider.com/news/stocks/therapy-stock-market-wall-street-layoffs-selloff-recession-fears-investing-2023-8,2023-08-27 12:15:00,Stock Market Turbulence Has Led to a Therapy Boom for Stressed Out Traders - Markets Insider ...,DGX,0.041466,0.104153,Neutral
Why Is Quest Diagnostics  ( DGX )  Down 0.9% Since Last Earnings Report?,https://www.zacks.com/stock/news/2140927/why-is-quest-diagnostics-dgx-down-09-since-last-earnings-report,2023-08-25 15:31:11,Quest Diagnostics (DGX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,DGX,0.43816,0.099569,Neutral
Minimal Residual Disease Testing Global Markets and Technology Research Report 2023-2028: Charting Cancer Treatment Trajectories - The Role of MRD Explored,https://www.prnewswire.com/news-releases/minimal-residual-disease-testing-global-markets-and-technology-research-report-2023-2028-charting-cancer-treatment-trajectories---the-role-of-mrd-explored-301909943.html,2023-08-25 14:30:00,Minimal Residual Disease Testing Global Markets and Technology Research Report 2023-2028: Charting Cancer ... PR ...,DGX,0.051886,0.07293,Neutral
End-of-Life Just Months Away for Quanum EHR - PracticeSuite Creates Easy Transition,https://www.benzinga.com/pressreleases/23/08/g33987834/end-of-life-just-months-away-for-quanum-ehr-practicesuite-creates-easy-transition,2023-08-22 15:30:00,"TAMPA, Fla., Aug. 22, 2023 ( GLOBE NEWSWIRE ) -- With only four months until Quest's Quanum EHR reaches its end-of-life date, many physicians are faced with difficult decisions.",DGX,0.109956,-0.02308,Neutral
Quest Diagnostics  ( DGX )  Base Volume Aids Amid Low COVID Tests,https://www.zacks.com/stock/news/2138252/quest-diagnostics-dgx-base-volume-aids-amid-low-covid-tests,2023-08-18 16:48:00,"Quest Diagnostics (DGX) continues to witness growth momentum in the cardiometabolic, endocrinology, infectious disease and carrier and prenatal genetic screening services.",DGX,0.585687,0.226699,Somewhat-Bullish
The Drug Screening Market size to grow by USD 6.6599 billion from 2022 to 2027; Advancements in Drug Screening ... - PR Newswire,https://www.prnewswire.com/news-releases/the-drug-screening-market-size-to-grow-by-usd-6-6599-billion-from-2022-to-2027-advancements-in-drug-screening-technologies-to-influence-market-growth---technavio-301903528.html,2023-08-18 02:30:00,The Drug Screening Market size to grow by USD 6.6599 billion from 2022 to 2027. Advancements in Drug Screening ... PR ...,DGX,0.038592,0.062178,Neutral
Why Bionano Genomics Stock Tanked Today,https://www.fool.com/investing/2023/08/14/why-bionano-genomics-stock-tanked-today/,2023-08-14 22:17:22,A CFO departure shines a light on some of the company's recent struggles.,DGX,0.135347,0.035766,Neutral
Reasons to Retain Quest Diagnostics  ( DGX )  Stock for Now,https://www.zacks.com/stock/news/2136208/reasons-to-retain-quest-diagnostics-dgx-stock-for-now,2023-08-14 14:15:00,Investors are optimistic about Quest Diagnostics (DGX) on the strength of the base business performance and acquisitions.,DGX,0.501986,0.474596,Bullish
Bionano Announces CFO Transition and Appointment of Gülsen Kama as Chief Financial Officer - Bionano Genomics  ( NASDAQ:BNGO ) ,https://www.benzinga.com/pressreleases/23/08/g33827406/bionano-announces-cfo-transition-and-appointment-of-g-lsen-kama-as-chief-financial-officer,2023-08-14 12:00:00,"SAN DIEGO, Aug. 14, 2023 ( GLOBE NEWSWIRE ) -- Bionano Genomics, Inc. BNGO today announced that Gülsen Kama will serve as its next Chief Financial Officer ( CFO ) , effective September 11, 2023.",DGX,0.085936,0.167827,Somewhat-Bullish
"Alzheimer's Disease Biomarkers Market Predicted to Reach USD 1.7 billion by 2031, Expanding at a 7.5% CAGR Says, Transparency Market Research Inc.",https://www.benzinga.com/pressreleases/23/08/g33826495/alzheimers-disease-biomarkers-market-predicted-to-reach-usd-1-7-billion-by-2031-expanding-at-a-7-5,2023-08-14 11:30:00,"Wilmington, Delaware, United States, Aug. 14, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global Alzheimer's disease biomarkers market is expected to be valued at US$ 953.54 million in 2023 and is likely to expand at a 7.5% CAGR until 2031.",DGX,0.040622,0.066816,Neutral
"Lyme Disease Diagnostics Market Size Worth USD 2.1 Billion in 2031, to Expand at a 3.8% CAGR Says, Transparency Market Research",https://www.benzinga.com/pressreleases/23/08/g33824735/lyme-disease-diagnostics-market-size-worth-usd-2-1-billion-in-2031-to-expand-at-a-3-8-cagr-says-tr,2023-08-14 10:30:00,"Wilmington, Delaware, United States, Aug. 14, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global Lyme disease diagnostics market is expected to total US$ 1.56 billion in 2023 and is expected to expand at a CAGR of 3.8% until 2031.",DGX,0.039033,0.152797,Somewhat-Bullish
More Alzheimer's Treatments Are Coming: This Company Can Help With Early Detection,https://www.fool.com/investing/2023/08/09/more-alzheimers-treatments-are-coming-this-company/,2023-08-09 13:53:00,"Alzheimer's is a huge problem, and earlier detection could make a big difference.",DGX,0.273552,0.306111,Somewhat-Bullish
Should People With No Symptoms Get A Diagnosis Of Alzheimer's Disease?,https://www.forbes.com/sites/howardgleckman/2023/08/08/should-people-with-no-symptoms-get-a-diagnosis-of-alzheimers-disease/,2023-08-08 14:47:26,The National Institute on Aging and the Alzheimer's Association have proposed revised clinical guidelines that would designate seven major stages of the brain disease.,DGX,0.050572,-0.116977,Neutral
"Vaginitis Diagnostics Market to reach USD 4.1 billion in 2031, expanding at a CAGR of 9.5%: TMR Report",https://www.benzinga.com/pressreleases/23/08/g33626008/vaginitis-diagnostics-market-to-reach-usd-4-1-billion-in-2031-expanding-at-a-cagr-of-9-5-tmr-repor,2023-08-08 12:15:00,"Wilmington, Delaware, United States, Aug. 08, 2023 ( GLOBE NEWSWIRE ) -- The global vaginitis diagnostics market is projected to flourish at a CAGR of 9.5% from 2022 to 2031. As per the report published by TMR, a valuation of US$ 4.1 billion is anticipated for the market in 2031.",DGX,0.039944,0.0,Neutral
Sage Therapeutics' stock drops 49% after FDA approves zuranolone for postpartum depression but not for major depressive disorder,https://www.marketwatch.com/story/sage-therapeutics-stock-craters-49-after-fda-approves-zuranolone-for-postpartum-depression-but-not-major-depressive-disorder-2648cefa,2023-08-07 14:46:00,"The good news on postpartum depression was offset by disappointment about major depressive disorder, which would be a far greater opportunity.",DGX,0.055109,-0.129849,Neutral
"Genetic Testing Market size to grow by USD 7,103.8 million from 2022 to 2027|The growing adoption of direct-to ... - PR Newswire",https://www.prnewswire.com/news-releases/genetic-testing-market-size-to-grow-by-usd-7-103-8-million-from-2022-to-2027the-growing-adoption-of-direct-to-consumer-genetic-tests-in-early-disease-diagnosis-is-a-major-trend--technavio-301891403.html,2023-08-03 15:10:00,"Genetic Testing Market size to grow by USD 7,103.8 million from 2022 to 2027|The growing adoption of direct-to ... PR ...",DGX,0.088964,0.012455,Neutral
First Alzheimer's disease risk assessment blood test for consumers hits market,https://www.foxbusiness.com/lifestyle/first-alzheimers-disease-risk-assessment-blood-test-consumers-hits-market,2023-07-31 16:32:03,Quest Diagnostics on Monday released the first blood test for consumer purchase that can help assess the risk of developing Alzheimer's disease. The AD-Detect Test for Alzheimer's Disease costs $399 and is available for purchase online and can assess a person's risk based on a brain protein that ...,DGX,0.327366,0.152886,Somewhat-Bullish
Quest Diagnostics launches first at-home blood test to assess risk of developing Alzheimer's disease,https://www.marketwatch.com/story/quest-diagnostics-launches-first-at-home-blood-test-to-assess-risk-of-developing-alzheimers-disease-20cd3639,2023-07-31 15:27:00,A simple test can detect the brain protein beta amyloid that is linked to the progression of Alzheimer's disease.,DGX,0.191929,0.010881,Neutral
Quest Diagnostics launches Alzheimer's blood test for consumers,https://www.reuters.com/business/healthcare-pharmaceuticals/quest-diagnostics-launches-alzheimers-blood-test-consumers-2023-07-31/,2023-07-31 11:10:00,"CHICAGO, July 31 ( Reuters ) - Quest Diagnostics ( DGX.N ) on Monday launched the first direct-to-consumer blood test to detect abnormal levels of beta amyloid, a key Alzheimer's protein which can appear years before dementia symptoms arise.",DGX,0.127456,-0.114349,Neutral
Quest Introduces First-To-Market Consumer-Initiated Blood Test for Alzheimer's Disease Risk Assessment on questhealth.com,https://www.prnewswire.com/news-releases/quest-introduces-first-to-market-consumer-initiated-blood-test-for-alzheimers-disease-risk-assessment-on-questhealthcom-301888653.html,2023-07-31 11:08:00,Quest Introduces First-To-Market Consumer-Initiated Blood Test for Alzheimer's Disease Risk Assessment on ... PR ...,DGX,0.229149,0.230092,Somewhat-Bullish
"Quest Diagnostics Stock Falls on Lower Q2 Revenue and Profits from Lower Productivity Effects, Tightened Outlook - Quest Diagnostics  ( NYSE:DGX ) ",https://www.benzinga.com/news/earnings/23/07/33389687/quest-diagnostics-stock-falls-on-lower-q2-revenue-and-profits-from-lower-productivity-effects-tight,2023-07-26 14:21:07,"Quest Diagnostics Inc DGX posted Q2 FY23 adjusted EPS of $2.30, down 2.5% Y/Y, beating the consensus of $2.27. Sales came in at $2.34 billion, a decline of 4.7% Y/Y, higher than the Wall Street estimate of $2.25 billion.",DGX,0.541149,0.181966,Somewhat-Bullish
"Quest Diagnostics  ( DGX )  Q2 Earnings Beat Estimates, FY View Up",https://www.zacks.com/stock/news/2127978/quest-diagnostics-dgx-q2-earnings-beat-estimates-fy-view-up,2023-07-26 14:10:00,Quest Diagnostics (DGX) delivers better-than-expected earnings and revenues in the second quarter of 2023.,DGX,0.380736,0.2391,Somewhat-Bullish
Quest Diagnostics  ( DGX )  Surpasses Q2 Earnings and Revenue Estimates,https://www.zacks.com/stock/news/2127567/quest-diagnostics-dgx-surpasses-q2-earnings-and-revenue-estimates,2023-07-26 11:55:04,"Quest Diagnostics (DGX) delivered earnings and revenue surprises of 3.14% and 4.22%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?",DGX,0.398148,0.108395,Neutral
Quest Diagnostics Reports Second Quarter 2023 Financial Results; Updates Guidance for Full Year 2023,https://www.prnewswire.com/news-releases/quest-diagnostics-reports-second-quarter-2023-financial-results-updates-guidance-for-full-year-2023-301885557.html,2023-07-26 10:45:00,Quest Diagnostics Reports Second Quarter 2023 Financial Results. Updates Guidance for Full Year 2023 PR ...,DGX,0.211191,0.247764,Somewhat-Bullish
"MedTech Stocks' Q2 Earnings Due on Jul 26: DGX, TMO and More",https://www.zacks.com/stock/news/2127087/medtech-stocks-q2-earnings-due-on-jul-26-dgx-tmo-and-more,2023-07-25 15:05:00,"MedTech companies' second-quarter results are likely to reflect a year-over-year decline. Let's see how DGX, TMO, EW and ALGN fare this time.",DGX,0.252987,-0.032404,Neutral
Quest Diagnostics  ( DGX )  Expected to Beat Earnings Estimates: Should You Buy?,https://www.zacks.com/stock/news/2123780/quest-diagnostics-dgx-expected-to-beat-earnings-estimates-should-you-buy,2023-07-19 14:01:26,Quest Diagnostics (DGX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,DGX,0.297661,0.151924,Somewhat-Bullish
"Quest Diagnostics, Keysight Technologies And A Stock Up 42% Year To Date On CNBC's 'Final Trades' - Quest Diagnostics  ( NYSE:DGX ) , Keysight Techs  ( NYSE:KEYS ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/07/33278897/quest-diagnostics-keysight-technologies-and-a-stock-up-42-year-to-date-on-cnbcs-final-tr,2023-07-19 12:58:20,"On CNBC's ""Halftime Report Final Trades,"" Jason Snipe of Odyssey Capital Advisors said he likes Quest Diagnostics Incorporated DGX here. He said the company benefitted tremendously during the Covid-19 era, but its non-Covid revenues continue to grow.",DGX,0.582526,0.500116,Bullish
CytoSorbents Appoints Alexander D'Amico as Chief Financial Officer,https://investingnews.com/cytosorbents-appoints-alexander-d-amico-as-chief-financial-officer/,2023-07-19 11:46:44,"CytoSorbents Corporation ( NASDAQ: CTSO ) , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announced the appointment of Alexander D'Amico as Chief Financial ...",DGX,0.02379,0.108936,Neutral
CytoSorbents Appoints Alexander D'Amico as Chief Financial Officer,https://www.globenewswire.com/news-release/2023/07/19/2707174/25359/en/CytoSorbents-Appoints-Alexander-D-Amico-as-Chief-Financial-Officer.html,2023-07-19 11:00:00,"PRINCETON, N.J., July 19, 2023 ( GLOBE NEWSWIRE ) -- CytoSorbents Corporation ( NASDAQ: CTSO ) , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announced the ...",DGX,0.024622,0.111354,Neutral
Quest Diagnostics  ( DGX )  to Post Q2 Earnings: What's in Store?,https://www.zacks.com/stock/news/2123100/quest-diagnostics-dgx-to-post-q2-earnings-whats-in-store,2023-07-18 16:03:00,Quest Diagnostics (DGX) second-quarter results are likely to have reflected the solid base business performance and benefits from acquisitions.,DGX,0.612212,0.413995,Bullish
Reasons to Retain Quest Diagnostics  ( DGX )  Stock for Now,https://www.zacks.com/stock/news/2123159/reasons-to-retain-quest-diagnostics-dgx-stock-for-now,2023-07-18 15:20:00,Investors are optimistic about Quest Diagnostics (DGX) on stronger base volume recovery and growth from strategic acquisitions.,DGX,0.329866,0.375352,Bullish
"In-vitro Diagnostics Market to grow at a CAGR of 6.89% from 2021 to 2026| Abbott Laboratories, Agilent Technologies Inc., ARKRAY Inc. and more to emerge as key players - Technavio",https://www.prnewswire.com/news-releases/in-vitro-diagnostics-market-to-grow-at-a-cagr-of-6-89--from-2021-to-2026-abbott-laboratories-agilent-technologies-inc-arkray-inc-and-more-to-emerge-as-key-players---technavio-301877804.html,2023-07-17 07:30:00,"In-vitro Diagnostics Market to grow at a CAGR of 6.89% from 2021 to 2026| Abbott Laboratories, Agilent Technologies ... PR ...",DGX,0.067441,0.065132,Neutral
Quest Diagnostics  ( DGX )  Brings New Test for Prostate Cancer,https://www.zacks.com/stock/news/2121087/quest-diagnostics-dgx-brings-new-test-for-prostate-cancer,2023-07-14 11:23:00,Quest Diagnostics (DGX) collaborates with Envision Sciences to bring a novel prosate cancer biomarker test.,DGX,0.38716,-0.084708,Neutral
Can Rite Aid  ( RAD )  Stock Bounce Back on Growth Endeavors?,https://www.zacks.com/stock/news/2118759/can-rite-aid-rad-stock-bounce-back-on-growth-endeavors,2023-07-10 14:50:00,"Despite drab demand and headwinds at Elixir Insurance, Rite Aid's (RAD) solid online show, strength in the Retail Pharmacy segment and cost-saving initiatives are likely to aid growth.",DGX,0.033846,0.117998,Neutral
Quest Diagnostics'  ( DGX )  New Pact to Get Home Fertility Test,https://www.zacks.com/stock/news/2118729/quest-diagnostics-dgx-new-pact-to-get-home-fertility-test,2023-07-10 14:15:00,The Proov Confirm home collection kit can be purchased now on Quest Diagnostics' questhealth.com for $29.,DGX,0.344302,0.119319,Neutral
"Zacks Industry Outlook Highlights Definitive Healthcare, Clover Health and Augmedix",https://www.zacks.com/stock/news/2118656/zacks-industry-outlook-highlights-definitive-healthcare-clover-health-and-augmedix,2023-07-10 12:42:00,"Healthcare, Clover Health and Augmedix are part of the Zacks Industry Outlook article.",DGX,0.030331,0.091446,Neutral
Analysis of Half a Billion Lipid Tests from Five Continents Reveals Wide Variation of Lipid-Associated Risk of Heart Disease by Country and Sex,https://www.prnewswire.com/news-releases/analysis-of-half-a-billion-lipid-tests-from-five-continents-reveals-wide-variation-of-lipid-associated-risk-of-heart-disease-by-country-and-sex-301872837.html,2023-07-10 11:30:00,Analysis of Half a Billion Lipid Tests from Five Continents Reveals Wide Variation of Lipid-Associated Risk of Heart ... PR ...,DGX,0.242285,0.205047,Somewhat-Bullish
"Thanks to viral megatests, a ""cold"" may not be so common anymore",https://www.cnn.com/2023/07/10/health/multiplex-tests-common-cold/index.html,2023-07-10 10:27:00,"Got a stuffy nose and a cough? If you go to an urgent care or ER, chances are that you may be able find out exactly what type of germ is making you sick, thanks to newer tests that don't look for just one pathogen at a time but sometimes screen for 18 to 20 viruses and bacteria.",DGX,0.045396,0.074658,Neutral
3 Medical Info Systems Stocks to Consider From a Prospering Industry,https://www.zacks.com/commentary/2118030/3-medical-info-systems-stocks-to-consider-from-a-prospering-industry,2023-07-07 15:04:00,"Zacks Medical Info Systems industry stocks like Definitive Healthcare (DH), Clover Health Investments (CLOV) and Augmedix (AUGX) are expected to gain from new normal trends.",DGX,0.03157,0.109287,Neutral
Quest Diagnostics  ( DGX )  Presents New Data on Disease Testing,https://www.zacks.com/stock/news/2116092/quest-diagnostics-dgx-presents-new-data-on-disease-testing,2023-07-03 14:55:00,Quest Diagnostics (DGX) is dedicated to create cutting-edge laboratory tests to help assess patient risk for dementia and other degenerative diseases.,DGX,0.488217,0.449058,Bullish
"Interest Rates, Housing, and Regulators Eyeing Big Acquisitions",https://www.fool.com/investing/2023/07/01/interest-rates-housing-and-regulators-eyeing-big-a/,2023-07-01 12:00:00,We've also got a look at two tickers worth watching: SPOT and SCHD.,DGX,0.01145,-0.011478,Neutral
"Drugs approved a decade ago can cure hepatitis C, but most infected Americans still can't get them, study shows",https://www.cnn.com/2023/06/29/health/hepatitis-c-treatment/index.html,2023-06-29 17:08:00,"For a decade now, the world has had highly effective medications for hepatitis C infections. In the United States, they've mostly been sitting on the shelf, according to a new study.",DGX,0.021504,0.009164,Neutral
"Demandbase Celebrates New and Renewing Relationships with Customers T-Mobile, Sprout Social, BNY Mellon, Appcast, Quest Diagnostics, Kraton, and Others",https://www.benzinga.com/pressreleases/23/06/n33040602/demandbase-celebrates-new-and-renewing-relationships-with-customers-t-mobile-sprout-social-bny-mel,2023-06-28 12:22:00,"The Smarter GTM™ Company Showcases Success with Customer Tricentis SAN FRANCISCO, June 28, 2023 /PRNewswire/ -- Demandbase, the Smarter GTM™ company that uses AI to help B2B organizations hit their revenue goals, today announces new customer relationships, significant wins, and noteworthy ...",DGX,0.209365,0.326255,Somewhat-Bullish
"Corporate Wellness Market size to grow by USD 29,208.51 million from 2022 to 2027: The increasing need to combat rising healthcare costs to be a market driver - Technavio",https://www.prnewswire.com/news-releases/corporate-wellness-market-size-to-grow-by-usd-29-208-51-million-from-2022-to-2027-the-increasing-need-to-combat-rising-healthcare-costs-to-be-a-market-driver---technavio-301861149.html,2023-06-26 12:30:00,"Corporate Wellness Market size to grow by USD 29,208.51 million from 2022 to 2027: The increasing need to combat ... PR ...",DGX,0.024904,0.125446,Neutral
Quest Diagnostics'  ( DGX )  New Buyout Expands Cancer Portfolio,https://www.zacks.com/stock/news/2111989/quest-diagnostics-dgx-new-buyout-expands-cancer-portfolio,2023-06-22 16:35:00,Quest Diagnostics (DGX) will use MRD technology to create new blood-based clinical lab services for solid tumour cancers that will be available starting in 2024.,DGX,0.464633,0.417514,Bullish
Quest Diagnostics  ( DGX )  Partners to Offer New Testing Service,https://www.zacks.com/stock/news/2110739/quest-diagnostics-dgx-partners-to-offer-new-testing-service,2023-06-20 15:22:00,Quest Diagnostics' (DGX) latest test indicates how different genes and their variants affect how a person reacts to drugs.,DGX,0.510588,0.503312,Bullish
"Drugs of Abuse  ( DOA )  Testing Market Size, Share And Growth Analysis For 2023-2032 As Per The Business Research Company's Drugs Of Abuse  ( DOA )  Testing Global Market Report 2023",https://www.benzinga.com/pressreleases/23/06/g32913436/drugs-of-abuse-doa-testing-market-size-share-and-growth-analysis-for-2023-2032-as-per-the-business,2023-06-19 15:40:00,"LONDON, June 19, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's drugs of abuse ( DOA ) testing Market Report 2023, the market will grow from $6 billion in 2022 to $6.6 billion in 2023, at a compound annual growth rate ( CAGR ) of more than 10%.",DGX,0.05654,-0.288008,Somewhat-Bearish
Think Twice Before Testing Your Hormones at Home,https://www.theatlantic.com/health/archive/2023/06/at-home-hormone-test-kits/674426/,2023-06-16 12:00:00,"Across the internet, a biological scapegoat has emerged for almost any mysterious medical symptom affecting women. Struggling with chronic fatigue, hair loss, brain fog, or dwindling sex drive? When no obvious explanation is at hand, an out-of-whack endocrine system must be to blame.",DGX,0.018626,0.00555,Neutral
FDA Readies Proposal for Increased Oversight on Lab-developed Tests - Quest Diagnostics  ( NYSE:DGX ) ,https://www.benzinga.com/government/23/06/32783227/fda-readies-proposal-for-increased-oversight-on-lab-developed-tests,2023-06-08 18:00:42,"The FDA is preparing to increase regulation of a widely used class of tests conducted by laboratories to detect cancer, measure cholesterol, and identify other health issues. The FDA is developing a proposal to ensure these tests' effectiveness and accuracy.",DGX,0.28387,0.177435,Somewhat-Bullish
Implied Volatility Surging for Quest Diagnostics  ( DGX )  Stock Options,https://www.zacks.com/stock/news/2105682/implied-volatility-surging-for-quest-diagnostics-dgx-stock-options,2023-06-08 12:46:00,Investors need to pay close attention to Quest Diagnostics (DGX) stock based on the movements in the options market lately.,DGX,0.553595,0.084444,Neutral
Quest Diagnostics'  ( DGX )  Contract Wins Aid Amid Volume Woes,https://www.zacks.com/stock/news/2104532/quest-diagnostics-dgx-contract-wins-aid-amid-volume-woes,2023-06-06 15:19:00,Quest Diagnostics (DGX) succeeds on contract wins in its reference and professional lab services offerings.,DGX,0.43789,0.121285,Neutral
Option Care  ( OPCH )  Surges 6.3%: Is This an Indication of Further Gains?,https://www.zacks.com/stock/news/2104338/option-care-opch-surges-63-is-this-an-indication-of-further-gains,2023-06-06 12:55:00,Option Care (OPCH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.,DGX,0.485711,0.037014,Neutral
"Truckers Testing Positive For Cannabis At Record Rates, 129,000 Prohibited, Exacerbating Supply Chain",https://www.benzinga.com/markets/cannabis/23/06/32704293/truckers-testing-positive-for-cannabis-at-record-rates-129-000-prohibited-exacerbating-supply-ch,2023-06-03 17:06:09,"The number of truck drivers testing positive for marijuana use rose by 9.2% in the first quarter of 2023, with a significant portion of those who failed their tests not participating in the return-to-work program, according to data from the federal Drug & Alcohol Clearinghouse reported Transport ...",DGX,0.092569,0.086861,Neutral
Quest Diagnostics to Speak at the Jefferies Global Healthcare Conference,https://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-the-jefferies-global-healthcare-conference-301841352.html,2023-06-02 15:19:00,Quest Diagnostics to Speak at the Jefferies Global Healthcare ... PR ...,DGX,0.528475,0.562102,Bullish
Reasons to Retain Quest Diagnostics  ( DGX )  Stock for Now,https://www.zacks.com/stock/news/2103021/reasons-to-retain-quest-diagnostics-dgx-stock-for-now,2023-06-02 12:40:00,Investors are optimistic about Quest Diagnostics (DGX) on the strength of the base business performance and its strategies to accelerate growth.,DGX,0.388879,0.404789,Bullish
"Genetic Testing Services Market Anticipated to Hit US$ 31.5 Billion by 2031, expanding at a CAGR of 8.4%: TMR Report",https://www.benzinga.com/pressreleases/23/05/g32605190/genetic-testing-services-market-anticipated-to-hit-us-31-5-billion-by-2031-expanding-at-a-cagr-of-,2023-05-26 21:30:00,"Wilmington, Delaware, United States, May 26, 2023 ( GLOBE NEWSWIRE ) -- The global genetic testing services market is projected to flourish at a CAGR of 8.4% from 2023 to 2031. As per the report published by TMR, the global genetic testing services market is expected to exceed a value of US$ 31.5 ...",DGX,0.043499,0.0,Neutral
3 No-Brainer Stocks to Buy in a Correction,https://www.fool.com/investing/2023/05/26/3-no-brainer-stocks-to-buy-in-a-correction/,2023-05-26 10:32:00,Stock market downturns present great opportunities to go shopping for wonderful stocks.,DGX,0.054983,0.07883,Neutral
Want Growing Passive Income? Consider Buying This Stock,https://www.fool.com/investing/2023/05/24/want-grow-passive-income-consider-buying-stock/,2023-05-24 09:48:00,This maker of diagnostics tests has delivered 13 years of dividend growth to shareholders.,DGX,0.433523,0.45251,Bullish
Positive marijuana tests following workplace accidents highest in 25 years,https://www.foxbusiness.com/lifestyle/positive-marijuana-tests-following-workplace-accidents-highest-25-years,2023-05-22 12:07:37,"The year 2022 marked the year that drug tests administered after workplace accidents showing positive results for marijuana reached the highest level in 25 years, according to a recent Quest Diagnostics analysis.",DGX,0.48457,0.358637,Bullish
More Americans injured on the job are testing positive for cannabis,https://www.marketwatch.com/story/more-americans-injured-on-the-job-are-testing-positive-for-cannabis-ab6f98d0,2023-05-18 16:13:00,"Quest Diagnostics, a major U.S. laboratory, recorded a 25-year high in those who have been injured and then tested positive for cannabis in their system.",DGX,0.275091,0.092396,Neutral
"Post-Accident Workforce Drug Positivity For Marijuana Reached 25-Year High In 2022, Quest Diagnostics Drug Testing Index Analysis Finds - Quest Diagnostics  ( NYSE:DGX ) ",https://www.benzinga.com/markets/cannabis/23/05/32466550/post-accident-workforce-drug-positivity-for-marijuana-reached-25-year-high-in-2022-quest-diagnos,2023-05-18 13:39:56,"The percentage of employees in the general U.S. workforce testing positive for marijuana following an on-the-job accident increased to its highest level in 25 years in 2022, according to a new analysis released by Quest Diagnostics DGX.",DGX,0.233556,0.040854,Neutral
Visionary Leadership: Going Beyond Protection to Make Security a Competitive Advantage Will Fuel the Discussion at the 2023 Silicon Valley CISO & Technology Executive Leadership Summit on June 1,https://www.benzinga.com/pressreleases/23/05/g32447563/visionary-leadership-going-beyond-protection-to-make-security-a-competitive-advantage-will-fuel-th,2023-05-17 15:02:59,"WESTPORT, Conn., May 17, 2023 ( GLOBE NEWSWIRE ) -- HMG Strategy, the World's #1 digital platform for enabling technology executives to reimagine the enterprise and reshape the business world, is excited to be hosting its 2023 Silicon Valley CISO & Technology Executive Leadership Summit at the ...",DGX,0.021274,0.0,Neutral
Exact Sciences Serves Investors Exactly What They Wished For - Exact Sciences  ( NASDAQ:EXAS ) ,https://www.benzinga.com/news/earnings/23/05/32422602/exact-sciences-serves-investors-exactly-what-they-wished-for,2023-05-16 20:38:50,Diagnostic and cancer test products provider Exact Sciences Corp. EXAS saw its shares spike over 17% on its Q1 2023 earnings results. The company is known for its flagship colon cancer detection test Cologuard.,DGX,0.114137,-0.201737,Somewhat-Bearish
Here's Why Investors Should Retain LabCorp  ( LH )  Stock for Now,https://www.zacks.com/stock/news/2096008/heres-why-investors-should-retain-labcorp-lh-stock-for-now,2023-05-16 18:32:00,Investors are optimistic about LabCorp (LH) on strategic partnerships and upbeat guidance.,DGX,0.046633,0.127523,Neutral
ARCPOINT APPOINTS BOB MANN AS PRESIDENT OF FRANCHISE GROUP,https://www.globenewswire.com/news-release/2023/05/15/2668651/0/en/ARCPOINT-APPOINTS-BOB-MANN-AS-PRESIDENT-OF-FRANCHISE-GROUP.html,2023-05-15 11:30:00,"Greenville, South Carolina, May 15, 2023 ( GLOBE NEWSWIRE ) -- ARCpoint Inc. ( TSXV: ARC ) ( the ""Company"" or ""ARCpoint"" ) a leading US-based franchise system providing drug testing, alcohol screening, DNA and clinical lab testing services, is pleased to announce that Mr. Bob Mann has been ...",DGX,0.03072,0.103144,Neutral
"Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In May - Bio-Rad Laboratories  ( NYSE:BIO ) , Accolade  ( NASDAQ:ACCD ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/05/32337889/top-5-health-care-stocks-that-could-lead-to-your-biggest-gains-in-may,2023-05-11 12:00:00,"The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down.",DGX,0.243701,-0.241122,Somewhat-Bearish
The Pillars Of A Good Job,https://www.forbes.com/sites/justcapital/2023/05/05/the-pillars-of-a-good-job/,2023-05-05 17:56:45,Many people have temporarily unlearned the connection between the urge to pay bills and the need to work. Stakeholder capitalism is key to rebuilding good jobs and increasing work satisfaction.,DGX,0.027257,-0.06213,Neutral
CIO Leadership: HMG Strategy to Recognize Visionary Leaders at the 2023 Silicon Valley CISO & Technology Executive Leadership Summit on May 11,https://www.benzinga.com/pressreleases/23/05/g32194108/cio-leadership-hmg-strategy-to-recognize-visionary-leaders-at-the-2023-silicon-valley-ciso-technol,2023-05-03 17:39:51,"WESTPORT, Conn., May 03, 2023 ( GLOBE NEWSWIRE ) -- HMG Strategy, the World's #1 digital platform for enabling technology executives to reimagine the enterprise and reshape the business world, is thrilled to be recognizing four exemplary global business technology leaders for their visionary ...",DGX,0.020903,0.0,Neutral
"Stocks making the biggest moves midday: Uber, Chegg, Dell, PacWest, SoFi & more",https://www.cnbc.com/2023/05/02/stocks-making-the-biggest-moves-midday-uber-chegg-dell-pacwest-sofi-more.html,2023-05-02 16:24:03,These are the stocks posting the largest moves in midday trading.,DGX,0.057352,0.008011,Neutral
Will Chart Analysts Notice Bad Omen on Quest Diagnostics's Chart - Quest Diagnostics  ( NYSE:DGX ) ,https://www.benzinga.com/markets/23/05/32163049/will-chart-analysts-notice-bad-omen-on-quest-diagnosticss-chart,2023-05-02 14:48:35,"If history is any guide, there may be trouble ahead for shares of Quest Diagnostics DGX. A so-called ""death cross"" has formed on its chart and, not surprisingly, this could be bearish for the stock. What To Know: Many traders use moving average crossover systems to make their decisions.",DGX,0.561184,-0.458171,Bearish
"Quest Diagnostics  ( NYSE:DGX )  Upgraded by StockNews.com to ""Buy""",https://www.defenseworld.net/2023/05/02/quest-diagnostics-nysedgx-upgraded-by-stocknews-com-to-buy.html,2023-05-02 09:22:46,StockNews.com upgraded shares of Quest Diagnostics ( NYSE:DGX - Get Rating ) from a hold rating to a buy rating in a research note released on Monday. Other analysts also recently issued reports about the company.,DGX,0.771825,0.350023,Bullish
"Alzheimer's patients may wait years to get treated with new drugs, putting them at risk of more severe disease",https://www.cnbc.com/2023/04/30/alzheimers-treatment-patients-may-wait-years-for-new-drugs.html,2023-04-30 13:00:01,Patients could face wait times ranging from 18 months to four years or more to get diagnosed and then treated for Alzheimer's disease.,DGX,0.029078,-0.012914,Neutral
Quest Diagnostics Q1 Earnings Surpass Expectations; COVID-19 Testing Revenues Slump 80% - Quest Diagnostics  ( NYSE:DGX ) ,https://www.benzinga.com/news/earnings/23/04/32042358/quest-diagnostics-q1-earnings-surpass-expectations-covid-19-testing-revenues-slump-80,2023-04-27 15:18:46,"Quest Diagnostics Inc DGX posted Q1 FY23 adjusted EPS of $2.04, down 36.6% Y/Y, beating the consensus of $1.97. Sales came in at $2.33 billion, a decline of 10.7% Y/Y, higher than the Wall Street estimate of $2.20 billion. Base business revenues rose 10.0%, driven by solid performance across ...",DGX,0.756655,0.201703,Somewhat-Bullish
"Quest Diagnostics  ( DGX )  Q1 Earnings Top Estimates, Margins Down",https://www.zacks.com/stock/news/2086181/quest-diagnostics-dgx-q1-earnings-top-estimates-margins-down,2023-04-27 14:41:00,Quest Diagnostics (DGX) base business registers growth in the first quarter of 2023.,DGX,0.427726,-0.077737,Neutral
Questex's Fierce Health Payer Summit Showcases Leadership and Innovation in the Evolving Payer Industry,https://www.benzinga.com/pressreleases/23/04/g32047660/questexs-fierce-health-payer-summit-showcases-leadership-and-innovation-in-the-evolving-payer-indu,2023-04-27 14:00:00,"NEW YORK, April 27, 2023 ( GLOBE NEWSWIRE ) -- Questex's Fierce Health Payer Summit, the flagship Fierce Healthcare event that showcases leadership and innovation in the payer industry, will take place November 2-3, 2023 at the Renaissance Austin Hotel, Austin TX.",DGX,0.077343,0.202124,Somewhat-Bullish
Quest Diagnostics beats profit estimates as routine testing demand returns,https://www.reuters.com/markets/us/quest-diagnostics-beats-profit-estimates-routine-testing-demand-returns-2023-04-27/,2023-04-27 13:31:00,Quest Diagnostics beats profit estimates as routine testing demand ... ...,DGX,0.238133,0.209114,Somewhat-Bullish
Quest Diagnostics  ( DGX )  Beats Q1 Earnings and Revenue Estimates,https://www.zacks.com/stock/news/2085697/quest-diagnostics-dgx-beats-q1-earnings-and-revenue-estimates,2023-04-27 12:05:18,"Quest Diagnostics (DGX) delivered earnings and revenue surprises of 3.55% and 5.80%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?",DGX,0.38588,0.141821,Neutral
Quest Diagnostics Reports First Quarter 2023 Financial Results; Updates Guidance for Full Year 2023,https://www.prnewswire.com/news-releases/quest-diagnostics-reports-first-quarter-2023-financial-results-updates-guidance-for-full-year-2023-301808696.html,2023-04-27 10:44:00,Quest Diagnostics Reports First Quarter 2023 Financial Results ... PR ...,DGX,0.221212,0.256554,Somewhat-Bullish
CIO Leadership: HMG Strategy to Recognize Visionary Leaders at the 2023 Florida CIO Executive Leadership Summit on May 11,https://www.benzinga.com/pressreleases/23/04/g31997215/cio-leadership-hmg-strategy-to-recognize-visionary-leaders-at-the-2023-florida-cio-executive-leade,2023-04-25 19:08:03,"WESTPORT, Conn., April 25, 2023 ( GLOBE NEWSWIRE ) -- HMG Strategy, the World's #1 digital platform for enabling technology executives to reimagine the enterprise and reshape the business world, is excited to be recognizing four exemplary global business technology leaders for their visionary ...",DGX,0.02214,0.0,Neutral
The Global Genetic Analysis Market size is expected to reach $22.31 billion by 2028 | Brandessence Market Research,https://www.prnewswire.com/news-releases/the-global-genetic-analysis-market-size-is-expected-to-reach-22-31-billion-by-2028--brandessence-market-research-301803924.html,2023-04-21 09:17:00,The Global Genetic Analysis Market size is expected to reach ... PR ...,DGX,0.03319,0.064881,Neutral
CIO Leadership: HMG Strategy to Recognize Visionary Leaders at the 2023 New Jersey CIO Executive Leadership Summit on May 18,https://www.benzinga.com/pressreleases/23/04/g31919657/cio-leadership-hmg-strategy-to-recognize-visionary-leaders-at-the-2023-new-jersey-cio-executive-le,2023-04-20 16:20:44,"WESTPORT, Conn., April 20, 2023 ( GLOBE NEWSWIRE ) -- HMG Strategy, the World's #1 digital platform for enabling technology executives to reimagine the enterprise and reshape the business world, is excited to be recognizing four exemplary global business technology leaders for their visionary ...",DGX,0.02212,0.0,Neutral
Henry Schein  ( HSIC )  to Report Q1 Earnings: What's in Store?,https://www.zacks.com/stock/news/2082024/henry-schein-hsic-to-report-q1-earnings-whats-in-store,2023-04-20 13:51:00,"Henry Schein's (HSIC) medical business is expected to have gained from improved U.S. patient traffic to physician offices, ultimate care sites and ambulatory surgical centers.",DGX,0.127456,0.08944,Neutral
Quest Diagnostics  ( DGX )  to Post Q1 Earnings: What's in Store?,https://www.zacks.com/stock/news/2081749/quest-diagnostics-dgx-to-post-q1-earnings-whats-in-store,2023-04-20 10:57:00,Quest Diagnostics' (DGX) first-quarter 2023 results are likely to reflect an impressive performance in its non-COVID-19 base business amid inflationary pressure and labor challenges.,DGX,0.626331,0.388288,Bullish
Quest Diagnostics Sees IBD RS Rating Climb To 72,https://www.investors.com/ibd-data-stories/quest-diagnostics-sees-ibd-rs-rating-climb-to-72/,2023-04-20 07:00:00,"Quest Diagnostics ( DGX ) had its Relative Strength ( RS ) Rating upgraded from 64 to 72 Thursday -- a welcome improvement, but still short of the 80 or higher score you look for. X When looking for the best stocks to buy and watch, keep a close on eye on relative price strength.",DGX,0.772973,0.270558,Somewhat-Bullish
ALLIED SPORTS PROMOTES EXECUTIVE BUSINESS LEADS,https://www.prnewswire.com/news-releases/allied-sports-promotes-executive-business-leads-301800345.html,2023-04-18 14:00:00,Agency announces new roles across its leadership team,DGX,0.081276,0.186992,Somewhat-Bullish
Align Technology  ( ALGN )  to Post Q1 Earnings: What's in Store?,https://www.zacks.com/stock/news/2080230/align-technology-algn-to-post-q1-earnings-whats-in-store,2023-04-18 13:23:00,Align Technology's (ALGN) first-quarter 2023 results are likely to witness impressive performance across its operating segments amid macroeconomic pressure.,DGX,0.138464,0.093254,Neutral
Quest Diagnostics Getting Closer To Key Technical Benchmark,https://www.investors.com/ibd-data-stories/quest-diagnostics-getting-closer-to-key-technical-benchmark/,2023-04-18 07:00:00,"The Relative Strength ( RS ) Rating for Quest Diagnostics ( DGX ) jumped into a new percentile Tuesday, as it got a lift from 66 to 71. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",DGX,0.869158,0.228017,Somewhat-Bullish
Quest Diagnostics  ( DGX )  Advances Access to Transplant Services,https://www.zacks.com/stock/news/2076056/quest-diagnostics-dgx-advances-access-to-transplant-services,2023-04-10 10:47:00,Quest Diagnostics' (DGX) upgrade to advanced diagnostics and support services is likely to feature personalized patient access to service centers and mobile phlebotomists.,DGX,0.372315,0.462574,Bullish
CIO Leadership: Tapping Innovative Technologies and Partnerships to Drive Cost Containment and Power Business Growth Will Fuel the Dialogue at the 2023 New Jersey CIO Executive Leadership Summit on May 18,https://www.benzinga.com/pressreleases/23/04/g31700203/cio-leadership-tapping-innovative-technologies-and-partnerships-to-drive-cost-containment-and-powe,2023-04-06 15:11:58,"WESTPORT, Conn., April 06, 2023 ( GLOBE NEWSWIRE ) -- HMG Strategy, the World's #1 digital platform for enabling technology executives to reimagine the enterprise and reshape the business world, is excited to be hosting its 2023 New Jersey CIO Executive Leadership Summit at The Madison Hotel on ...",DGX,0.0428,0.0,Neutral
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar,https://www.zacks.com/stock/news/2075390/these-2-medical-stocks-could-beat-earnings-why-they-should-be-on-your-radar,2023-04-06 12:50:07,Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.,DGX,0.372448,0.364994,Bullish
Stocks Showing Improving Market Leadership: Option Care Health Earns 81 RS Rating,https://www.investors.com/ibd-data-stories/stocks-showing-improving-market-leadership-option-care-health-earns-81-rs-rating/,2023-04-06 07:00:00,Stocks Showing Improving Market Leadership: Option Care Health ... Investor's Business Daily ...,DGX,0.323078,0.0,Neutral
"Zacks Industry Outlook Highlights Inspire Medical Systems, Olink Holding and Health Catalyst",https://www.zacks.com/stock/news/2074631/zacks-industry-outlook-highlights-inspire-medical-systems-olink-holding-and-health-catalyst,2023-04-05 09:22:00,"Inspire Medical Systems, Olink Holding and Health Catalyst have been highlighted in this Industry Outlook article.",DGX,0.029184,0.090934,Neutral
Notice convening the Annual General Meeting in BioPorto A/S,https://www.globenewswire.com/news-release/2023/04/05/2641357/0/en/Notice-convening-the-Annual-General-Meeting-in-BioPorto-A-S.html,2023-04-05 06:35:00,"April 5, 2023Announcement no. ...",DGX,0.00945,0.032383,Neutral
3 Medical Info Systems Stocks Countering Industry-wide Headwinds,https://www.zacks.com/commentary/2074312/3-medical-info-systems-stocks-countering-industry-wide-headwinds,2023-04-04 15:16:00,"Zacks Medical Info Systems industry stocks like Inspire Medical Systems (INSP), Olink Holding (OLK) and Health Catalyst (HCAT) are expected to gain even as COVID-19 severity fades.",DGX,0.030369,0.113634,Neutral
"Archer-Daniels, WestRock And Other Comeback Stock Candidates",https://www.forbes.com/sites/johndorfman/2023/04/03/archer-daniels-westrock-and-other-comeback-stock-candidates/,2023-04-03 19:46:04,These stocks have been smacked down in the latest quarter but I believe they will rise again.,DGX,0.057628,0.0,Neutral
CIO Leadership: The Call for Visionary Leadership in the Face of Global Economic Pressures Will Drive the Discussion at the 2023 Florida CIO Executive Leadership Summit on May 11,https://www.benzinga.com/pressreleases/23/03/g31589848/cio-leadership-the-call-for-visionary-leadership-in-the-face-of-global-economic-pressures-will-dri,2023-03-30 16:51:34,"WESTPORT, Conn., March 30, 2023 ( GLOBE NEWSWIRE ) -- HMG Strategy, the World's #1 digital platform for enabling technology executives to reimagine the enterprise and reshape the business world, is excited to be hosting its 2023 Florida CIO Executive Leadership Summit at the Margaritaville ...",DGX,0.020283,0.0,Neutral
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings,https://www.zacks.com/stock/news/2072323/how-to-boost-your-portfolio-with-top-medical-stocks-set-to-beat-earnings,2023-03-30 12:50:06,Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.,DGX,0.315628,0.276764,Somewhat-Bullish
Quest Diagnostics  ( DGX )  Upgraded to Buy: What Does It Mean for the Stock?,https://www.zacks.com/stock/news/2071997/quest-diagnostics-dgx-upgraded-to-buy-what-does-it-mean-for-the-stock,2023-03-29 16:00:06,"Quest Diagnostics (DGX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).",DGX,0.364275,0.354956,Bullish
Reasons to Retain Quest Diagnostics  ( DGX )  Stock for Now,https://www.zacks.com/stock/news/2071400/reasons-to-retain-quest-diagnostics-dgx-stock-for-now,2023-03-28 15:12:00,Investors are optimistic about Quest Diagnostics (DGX) on solid fourth-quarter 2022 performance and its strategies to accelerate growth.,DGX,0.524949,0.502364,Bullish
Quest Diagnostics  ( DGX )  Introduces New Post-COVID-19 Panels,https://www.zacks.com/stock/news/2070872/quest-diagnostics-dgx-introduces-new-post-covid-19-panels,2023-03-27 15:28:00,"Quest Diagnostics' (DGX) latest panels provide consumers a deeper look into their health, helping to prepare them for meaningful discussions with their healthcare providers ...",DGX,0.270373,0.152029,Somewhat-Bullish
Pneumonia testing market size is set to grow by USD 709 million from 2022 to 2027; The rising number of M and A and new product launches are a key trend - Technavio,https://www.prnewswire.com/news-releases/pneumonia-testing-market-size-is-set-to-grow-by-usd-709-million-from-2022-to-2027-the-rising-number-of-m-and-a-and-new-product-launches-are-a-key-trend---technavio-301781432.html,2023-03-27 10:56:00,Pneumonia testing market size is set to grow by USD 709 million ... PR ...,DGX,0.029728,0.003889,Neutral
Quest Diagnostics  ( DGX )  Advances Transplant Testing Service,https://www.zacks.com/stock/news/2069682/quest-diagnostics-dgx-advances-transplant-testing-service,2023-03-23 15:19:00,"These services by Quest Diagnostics (DGX) are available to recipients and living donors across the United States (excluding Alaska and Hawaii), broadening access for both donor and patient.",DGX,0.49084,0.251442,Somewhat-Bullish
CIO Leadership: The Female Tech Leader as Enterprise Change Agent Will Power the Discussion at the 2023 Global Women in Technology Summit on April 13,https://www.benzinga.com/pressreleases/23/03/g31462671/cio-leadership-the-female-tech-leader-as-enterprise-change-agent-will-power-the-discussion-at-the-,2023-03-22 18:33:59,"WESTPORT, Conn., March 22, 2023 ( GLOBE NEWSWIRE ) -- HMG Strategy, the World's #1 digital platform for enabling technology executives to reimagine the enterprise and reshape the business world, is excited to be hosting its first in-person 2023 Global Women in Technology Summit at the Harvard ...",DGX,0.018802,0.0,Neutral
Roche teams up with Lilly to validate Alzheimer's blood test,https://www.reuters.com/business/healthcare-pharmaceuticals/roche-teams-up-with-lilly-validate-alzheimers-blood-test-2023-03-22/,2023-03-22 06:13:00,"[1/2] A 3D printed Lilly logo and test tubes are seen in this Illustration taken, October 18, 2022. REUTERS/Dado Ruvic/Illustration",DGX,0.076847,0.169343,Somewhat-Bullish
Quest Diagnostics  ( DGX )  Acquires Northern Light Laboratory,https://www.zacks.com/stock/news/2068572/quest-diagnostics-dgx-acquires-northern-light-laboratory,2023-03-21 14:43:00,Quest Diagnostics (DGX) now offers professional laboratory management services for nine of Northern Light Health's hospital laboratories.,DGX,0.563609,0.390969,Bullish
Why Investors Need to Take Advantage of These 2 Medical Stocks Now,https://www.zacks.com/stock/news/2068412/why-investors-need-to-take-advantage-of-these-2-medical-stocks-now,2023-03-21 12:50:07,Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.,DGX,0.382925,0.419093,Bullish
Drug Testing Market Size to Cross USD 15.7 Bn by 2033 with CAGR of 5.3% | Transparency Market Research,https://www.benzinga.com/pressreleases/23/03/g31423156/drug-testing-market-size-to-cross-usd-15-7-bn-by-2033-with-cagr-of-5-3-transparency-market-researc,2023-03-20 15:30:00,"Wilmington, Delaware, United States, March 20, 2023 ( GLOBE NEWSWIRE ) -- According to the latest research by Transparency Market Research, the drug testing market was estimated to attain a global market valuation of US$ 6.3 billion in the year 2022.",DGX,0.077972,0.159424,Somewhat-Bullish
"Quest Diagnostics  ( DGX )  Updates Its Strategic Focus, LT Growth",https://www.zacks.com/stock/news/2067964/quest-diagnostics-dgx-updates-its-strategic-focus-lt-growth,2023-03-20 13:45:00,Quest Diagnostics (DGX) is building strong platforms to focus on high-growth areas like molecular genomics and oncology.,DGX,0.433523,0.363083,Bullish
Quest Diagnostics Completes Acquisition of Northern Light Laboratory in Maine,https://www.prnewswire.com/news-releases/quest-diagnostics-completes-acquisition-of-northern-light-laboratory-in-maine-301776071.html,2023-03-20 12:40:00,Quest Diagnostics Completes Acquisition of Northern Light ... PR ...,DGX,0.43789,0.57417,Bullish
CIO Leadership: HMG Strategy Celebrates Extraordinary Leaders at the 2023 New York CIO Summit of America with the Global Women in Technology Summit on April 13,https://www.benzinga.com/pressreleases/23/03/g31386350/cio-leadership-hmg-strategy-celebrates-extraordinary-leaders-at-the-2023-new-york-cio-summit-of-am,2023-03-16 18:22:07,"WESTPORT, Conn., March 16, 2023 ( GLOBE NEWSWIRE ) -- HMG Strategy, the World's #1 digital platform for enabling technology executives to reimagine the enterprise and reshape the business world, is excited to be recognizing outstanding business technology leaders who are making a difference in ...",DGX,0.018583,0.0,Neutral
UiPath  ( PATH )  Q4 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/03/15/uipath-path-q4-2023-earnings-call-transcript/,2023-03-16 01:00:20,"PATH earnings call for the period ending December 31, 2022.",DGX,0.005099,0.119778,Neutral
Here's Why Investors Should Retain LabCorp  ( LH )  Stock for Now,https://www.zacks.com/stock/news/2065620/heres-why-investors-should-retain-labcorp-lh-stock-for-now,2023-03-14 16:46:00,Investors are optimistic about LabCorp (LH) backed by strength in its Drug Development business.,DGX,0.044885,0.124096,Neutral
"Silicon Valley Bank fallout, inflation data, FedEx earnings top week ahead",https://www.foxbusiness.com/markets/silicon-valley-bank-fallout-inflation-data-fedex-earnings-top-week-ahead,2023-03-12 15:05:18,"It will be a busy week ahead for investors with all eyes on embattled Silicon Valley Bank as the fallout continues, additionally a boatload of economic data will be released including two key inflation reports. is coming off a down week after the collapse of Silicon Valley Bank sent shock waves ...",DGX,0.043738,-0.037612,Neutral
CIO Leadership: HMG Strategy Celebrates Exceptional Leaders at the 2023 Dallas CIO Executive Leadership Summit on April 6,https://www.benzinga.com/pressreleases/23/03/g31281866/cio-leadership-hmg-strategy-celebrates-exceptional-leaders-at-the-2023-dallas-cio-executive-leader,2023-03-09 17:21:16,"WESTPORT, Conn., March 09, 2023 ( GLOBE NEWSWIRE ) -- HMG Strategy, the World's #1 digital platform for enabling technology executives to reimagine the enterprise and reshape the business world, is excited to be recognizing outstanding business technology leaders who are making a difference in ...",DGX,0.020335,0.0,Neutral
Is This Healthcare Stock a Buy for Dividend Growth Investors?,https://www.fool.com/investing/2023/03/07/is-this-healthcare-stock-a-buy-for-dividend-growth/,2023-03-07 15:15:00,This maker of diagnostics tests just announced that it will be sending more cash to its shareholders.,DGX,0.759885,0.372446,Bullish
Quest Diagnostics Board of Directors Elects James E. Davis Chairman of the Board,https://www.prnewswire.com/news-releases/quest-diagnostics-board-of-directors-elects-james-e-davis-chairman-of-the-board-301762477.html,2023-03-03 21:30:00,Quest Diagnostics Board of Directors Elects James E. Davis ... PR ...,DGX,0.382193,0.48042,Bullish
Ensign Group's  ( ENSG )  Buyout Consolidates Colorado Presence,https://www.zacks.com/stock/news/2061553/ensign-groups-ensg-buyout-consolidates-colorado-presence,2023-03-03 14:44:00,"The Ensign Group (ENSG) buys two skilled nursing facilities in Colorado, aiming to expand its portfolio of nursing homes in the state.",DGX,0.23281,0.080051,Neutral
Are Investors Undervaluing Quest Diagnostics  ( DGX )  Right Now?,https://www.zacks.com/stock/news/2061557/are-investors-undervaluing-quest-diagnostics-dgx-right-now,2023-03-03 14:40:12,"Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",DGX,0.59972,0.38585,Bullish
Reasons to Add Quest Diagnostics  ( DGX )  Stock to Your Portfolio,https://www.zacks.com/stock/news/2059812/reasons-to-add-quest-diagnostics-dgx-stock-to-your-portfolio,2023-02-28 14:35:00,Investors continue to be optimistic about Quest Diagnostics (DGX) on its accelerated growth strategy and improvements in base volumes.,DGX,0.594341,0.523487,Bullish
Todos Medical Provides Corporate Update,https://www.globenewswire.com/news-release/2023/02/23/2614554/0/en/Todos-Medical-Provides-Corporate-Update.html,2023-02-23 15:30:00,"New York, NY, and Tel Aviv, ISRAEL, Feb. 23, 2023 ( GLOBE NEWSWIRE ) -- via NewMediaWire -- Todos Medical, Ltd. ( OTCQB: TOMDF ) , a comprehensive medical diagnostics and related solutions company, today provided a corporate update for shareholders.",DGX,0.01978,0.092445,Neutral
"Quest Diagnostics  ( DGX )  Base Business Growth Robust, Volume Up",https://www.zacks.com/stock/news/2056939/quest-diagnostics-dgx-base-business-growth-robust-volume-up,2023-02-21 15:50:00,"Quest Diagnostics (DGX) starts to benefit from incentives related to these value-based contracts, which help demonstrate the value of these strategic relationships.",DGX,0.392362,0.291015,Somewhat-Bullish
Labcorp beats quarterly profit estimates,https://www.reuters.com/business/healthcare-pharmaceuticals/labcorp-beats-quarterly-profit-estimates-2023-02-16/,2023-02-16 12:07:00,"Feb 16 ( Reuters ) - Laboratory Corp of America Holdings ( LH.N ) on Thursday beat quarterly profit estimates, helped by strength in its diagnostics business and demand for its drug development services.",DGX,0.255641,-0.135199,Neutral
"Quest Diagnostics Teams Up with Tower Health to Deliver High-Value, Innovative Laboratory Services - Quest Diagnostics  ( NYSE:DGX ) ",https://www.benzinga.com/pressreleases/23/02/n30938940/quest-diagnostics-teams-up-with-tower-health-to-deliver-high-value-innovative-laboratory-services,2023-02-16 11:45:00,"SECAUCUS, N.J. and WEST READING, Pa., Feb. 16, 2023 /PRNewswire/ -- Quest Diagnostics DGX, the world's leading provider of diagnostic information services, and Tower Health, a regional integrated healthcare system in Pennsylvania, are teaming up to enhance the quality and value of diagnostic ...",DGX,0.422661,0.619624,Bullish
Quest Diagnostics  ( DGX )  New Pact to Boost Laboratory Services,https://www.zacks.com/stock/news/2054768/quest-diagnostics-dgx-new-pact-to-boost-laboratory-services,2023-02-15 16:17:00,Quest Diagnostics' (DGX) recent agreement is intended to offer advanced and quality clinical laboratory services in the greater New York region and beyond.,DGX,0.597724,0.722229,Bullish
2 Dividend Stocks That Recently Boosted Their Payouts by More Than 7%,https://www.fool.com/investing/2023/02/15/2-dividend-stocks-that-recently-boosted-payouts/,2023-02-15 13:53:00,These companies may not be finished raising their dividend payments as they both have low payout ratios.,DGX,0.213674,0.177163,Somewhat-Bullish
3 MedTech Stocks Likely to Beat Estimates This Earnings Season,https://www.zacks.com/stock/news/2051436/3-medtech-stocks-likely-to-beat-estimates-this-earnings-season,2023-02-08 12:42:00,"MedTech companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how EXAS, MDT and IART are poised ahead of their earnings releases.",DGX,0.122894,-0.002363,Neutral
Quest Diagnostics  ( NYSE:DGX )  Stock Rating Lowered by StockNews.com,https://www.defenseworld.net/2023/02/05/quest-diagnostics-nysedgx-stock-rating-lowered-by-stocknews-com.html,2023-02-05 09:16:46,Quest Diagnostics ( NYSE:DGX ) Stock Rating Lowered by ... Defense World ...,DGX,0.809819,0.388058,Bullish
Quest Diagnostics  ( NYSE:DGX )  Downgraded by StockNews.com,https://www.etfdailynews.com/2023/02/05/quest-diagnostics-nysedgx-downgraded-by-stocknews-com/,2023-02-05 09:16:42,"Quest Diagnostics ( NYSE:DGX - Get Rating ) was downgraded by equities researchers at StockNews.com from a ""buy"" rating to a ""hold"" rating in a note issued to investors on Friday. DGX has been the topic of several other research reports. Robert W.",DGX,0.793719,0.268279,Somewhat-Bullish
"Quest Diagnostics  ( DGX )  Q4 Earnings Top Estimates, Margin Down",https://www.zacks.com/stock/news/2049156/quest-diagnostics-dgx-q4-earnings-top-estimates-margin-down,2023-02-02 18:58:00,Improvement within Quest Diagnostics' (DGX) legacy base business contributes to Q4 performance.,DGX,0.405651,0.298344,Somewhat-Bullish
WHO counted nearly 20 million new COVID cases in latest month as it shifts from weekly reporting schedule,https://www.marketwatch.com/story/who-counted-nearly-20-million-new-covid-cases-in-latest-month-as-it-shifts-from-weekly-reporting-schedule-11675354564,2023-02-02 16:16:00,"The World Health Organization said nearly 20 million new COVID cases were recorded in the 28 days through Jan. 29, down 78% from the previous 28 days.",DGX,0.123526,0.058045,Neutral
"As of 2027, the HPV Testing and Pap Test Market is expected to reach US$ 9.2 billion at a CAGR of 13.2% - Exclusive Report by MarketsandMarkets™",https://www.benzinga.com/pressreleases/23/02/g30687087/as-of-2027-the-hpv-testing-and-pap-test-market-is-expected-to-reach-us-9-2-billion-at-a-cagr-of-13,2023-02-02 13:20:00,"Chicago, Feb. 02, 2023 ( GLOBE NEWSWIRE ) -- According to the new market research report published by MarketsandMarkets, ""HPV Testing and Pap Test Market Size, Growth by Test Type ( HPV Testing ( Follow-Up HPV Testing, Co- Testing, Primary HPV Testing ) , PAP Test ) , End User ( Laboratories, ...",DGX,0.043658,0.027253,Neutral
Quest Diagnostics  ( DGX )  Beats Q4 Earnings and Revenue Estimates,https://www.zacks.com/stock/news/2048219/quest-diagnostics-dgx-beats-q4-earnings-and-revenue-estimates,2023-02-02 13:05:08,"Quest Diagnostics (DGX) delivered earnings and revenue surprises of 4.21% and 3.56%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?",DGX,0.393977,0.214572,Somewhat-Bullish
QUEST DIAGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS; PROVIDES GUIDANCE FOR FULL YEAR 2023,https://www.prnewswire.com/news-releases/quest-diagnostics-reports-fourth-quarter-and-full-year-2022-financial-results-provides-guidance-for-full-year-2023-301736688.html,2023-02-02 11:45:00,QUEST DIAGNOSTICS REPORTS FOURTH QUARTER AND FULL ... PR ...,DGX,0.206157,0.263443,Somewhat-Bullish
"MedTech Stocks' Earnings to Watch on Feb 2: BDX, DGX & CNMD",https://www.zacks.com/stock/news/2047600/medtech-stocks-earnings-to-watch-on-feb-2-bdx-dgx-cnmd,2023-02-01 14:07:00,"Medical Device players are likely to have benefited from the reopening of economies and several efforts to combat staffing challenges. Let's see how BDX, DGX and CNMD are likely to fare this time.",DGX,0.391583,0.008227,Neutral
"With 10% CAGR, Autoimmune Disease Testing Market Size to Surpass USD 10.75 Billion by 2029",https://www.benzinga.com/pressreleases/23/02/g30661775/with-10-cagr-autoimmune-disease-testing-market-size-to-surpass-usd-10-75-billion-by-2029,2023-02-01 10:03:08,"Pune, India, Feb. 01, 2023 ( GLOBE NEWSWIRE ) -- The global autoimmune disease testing market size was valued at USD 4.84 billion in 2021. The market is projected to grow from USD 5.52 billion in 2022 to USD 10.75 billion by 2029, exhibiting a CAGR of 10.0% during the forecast period.",DGX,0.045918,0.0,Neutral
Carrier Screening Market Size to Reach $6.5 Billion by 2031: Says AMR,https://www.benzinga.com/pressreleases/23/02/g30661198/carrier-screening-market-size-to-reach-6-5-billion-by-2031-says-amr,2023-02-01 08:42:06,"Portland, OR, Feb. 01, 2023 ( GLOBE NEWSWIRE ) -- A new business intelligence report released by Allied Market Research, the global Carrier Screening Market size was estimated at $1.8 billion in 2021 and is expected to hit $6.5 billion by 2031, registering a CAGR of 13.8% from 2022 to 2031.",DGX,0.029256,0.1689,Somewhat-Bullish
Global Precision Medicine Market Competitive Landscape and Trends - By The Business Research Company,https://www.prnewswire.com/news-releases/global-precision-medicine-market-competitive-landscape-and-trends--by-the-business-research-company-301734691.html,2023-01-31 12:37:00,Global Precision Medicine Market Competitive Landscape and ... PR ...,DGX,0.05749,0.040957,Neutral
"With 5.2% CAGR, Point of Care Diagnostics Market Size to Surpass USD 51.94 Billion by 2029 | Report by Fortune Business Insights",https://www.benzinga.com/pressreleases/23/01/g30598973/with-5-2-cagr-point-of-care-diagnostics-market-size-to-surpass-usd-51-94-billion-by-2029-report-by,2023-01-27 08:50:17,"Pune, India, Jan. 27, 2023 ( GLOBE NEWSWIRE ) -- The global Point of Care Diagnostics Market size was valued at USD 46.65 billion in 2021. It is estimated to rise from USD 36.37 billion in 2022 to USD 51.94 billion by 2029, at a 5.2% CAGR during the forecast period.",DGX,0.04111,0.0,Neutral
Quest Diagnostics  ( DGX )  to Report Q4 Earnings: What's in Store?,https://www.zacks.com/stock/news/2043452/quest-diagnostics-dgx-to-report-q4-earnings-whats-in-store,2023-01-24 16:50:00,"Quest Diagnostics (DGX) ramps up investments to accelerate growth in the base business, particularly in advanced diagnostics and direct-to-consumer testing.",DGX,0.516971,0.364196,Bullish
"More Americans Know Their Horoscope Sign Than Their Blood Type, Survey Reveals",https://www.prnewswire.com/news-releases/more-americans-know-their-horoscope-sign-than-their-blood-type-survey-reveals-301727634.html,2023-01-23 14:05:00,More Americans Know Their Horoscope Sign Than Their Blood ... PR ...,DGX,0.148045,0.248362,Somewhat-Bullish
"Down 40% in 2022, Can Exact Sciences Recover in 2023?",https://www.fool.com/investing/2023/01/23/down-40-in-2022-can-exact-sciences-recover-in-2023/,2023-01-23 10:43:00,"Investors are attracted to its leading position in the market for early cancer detection, but the persistent losses its been reporting are enough to make anyone nervous.",DGX,0.062926,0.106205,Neutral
"Drug Testing Market Value to Reach US$ 15.7 Billion by 2033: Transparency Market Research, Inc. Study",https://www.prnewswire.com/news-releases/drug-testing-market-value-to-reach-us-15-7-billion-by-2033-transparency-market-research-inc-study-301726896.html,2023-01-20 15:00:00,Drug Testing Market Value to Reach US$ 15.7 Billion by 2033 ... PR ...,DGX,0.047844,0.147756,Neutral
"Wireless Brain Sensors Market is expected grow the CAGR of 10.84% during 2022-2209 Competitive Landscape, Key Players Benchmarking, and Forecast to 2029",https://www.benzinga.com/pressreleases/23/01/g30477410/wireless-brain-sensors-market-is-expected-grow-the-cagr-of-10-84-during-2022-2209-competitive-land,2023-01-19 09:23:29,"Pune, Jan. 19, 2023 ( GLOBE NEWSWIRE ) -- Maximize Market research has published a market intelligence and industry analysis report on ""Wireless Brain Sensors Market"".",DGX,0.03878,0.001928,Neutral
"Lung Cancer Screening Market Worth USD 4.13 Bn by 2029 Technological advancement, and key benchmarking of market players",https://www.benzinga.com/pressreleases/23/01/g30456038/lung-cancer-screening-market-worth-usd-4-13-bn-by-2029-technological-advancement-and-key-benchmark,2023-01-18 08:16:34,"Portland, Jan. 18, 2023 ( GLOBE NEWSWIRE ) -- According to the ""Lung Cancer Screening Market"" research published by Maximize Market Research, the market is expected to grow from USD 2.18 billion in 2021 to USD 4.13 billion in 2029, at a CAGR of 8.32 percent during the forecast period from 2022 ...",DGX,0.027603,0.280155,Somewhat-Bullish
Lab Corp. of America Shows Rising Relative Price Performance; Still Shy Of Key Threshold,https://www.investors.com/ibd-data-stories/lab-corp-of-america-shows-rising-relative-price-performance-still-shy-of-key-threshold/,2023-01-18 08:00:00,Lab Corp. of America Shows Rising Relative Price Performance. Still ... Investor's Business Daily ...,DGX,0.299478,0.0,Neutral
"Solid Tumor Testing Market Worth USD 59.45 Bn by 2029 Recent trends, mergers and acquisitions, region-wise growth analysis along with challenges",https://www.benzinga.com/pressreleases/23/01/g30434482/solid-tumor-testing-market-worth-usd-59-45-bn-by-2029-recent-trends-mergers-and-acquisitions-regio,2023-01-17 10:33:28,"Pune, Jan. 17, 2023 ( GLOBE NEWSWIRE ) -- According to the ""Solid Tumor Testing Market"" research published by Maximize Market Research, the market is expected to grow from USD 32.48 billion in 2021 to USD 59.45 billion in 2029, at a CAGR of 7.85 percent during the forecast period from 2022 to ...",DGX,0.028592,0.082166,Neutral
3 Medical Info Systems Stocks Braving Industry-wide Headwinds,https://www.zacks.com/commentary/2039485/3-medical-info-systems-stocks-braving-industry-wide-headwinds,2023-01-17 09:10:00,"Zacks Medical Info Systems industry stocks like 10x Genomics (TXG), NextGen Healthcare (NXGN) and Health Catalyst (HCAT) are expected to gain as COVID-19 severity fades.",DGX,0.03014,0.113524,Neutral
Biomarkers Market is expected to grow from USD 66.6 billion in 2022 to USD 183.42 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30427462/biomarkers-market-is-expected-to-grow-from-usd-66-6-billion-in-2022-to-usd-183-42-billion-by-2030-,2023-01-16 13:00:00,"Pune India, Jan. 16, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the biomarkers market is operating and is ...",DGX,0.024396,0.044526,Neutral
"S&P 500 Futures Decline in Premarket Trading; Tesla, Logitech International Lag",https://www.barrons.com/articles/s-p-500-futures-decline-in-premarket-trading-tesla-logitech-international-lag-01673613049,2023-01-13 12:30:00,"S&P 500 Futures Decline in Premarket Trading. Tesla, Logitech International Lag ...",DGX,0.876064,0.025713,Neutral
Can Rite Aid  ( RAD )  Get Back on Track Via Solid Growth Efforts?,https://www.zacks.com/stock/news/2038581/can-rite-aid-rad-get-back-on-track-via-solid-growth-efforts,2023-01-12 16:26:00,"Rite Aid (RAD) is reeling under elevated expenses. Yet, online strength, led by expanded delivery services, increased non-COVID prescriptions, and cost-saving initiatives, are likely to aid.",DGX,0.044469,0.116343,Neutral
"StockNews.com Upgrades Quest Diagnostics  ( NYSE:DGX )  to ""Buy""",https://reporter.am/2023/01/12/stocknews-com-upgrades-quest-diagnostics-nysedgx-to-buy.html,2023-01-12 08:00:42,"Quest Diagnostics ( NYSE:DGX - Get Rating ) was upgraded by stock analysts at StockNews.com from a ""hold"" rating to a ""buy"" rating in a report issued on Tuesday. A number of other equities analysts also recently issued reports on the company.",DGX,0.772528,0.495801,Bullish
Hemp Stock News - Global Hemp Group  ( CSE: GHG )  Announces Execution of Binding LOI with Apollon Formularies PLC,https://www.investorideas.com/news/2023/cannabis/01111CSE-GHG.asp,2023-01-11 16:47:42,Hemp Stock News - Global Hemp Group ( CSE: GHG ) Announces ... ...,DGX,0.038448,0.016212,Neutral
Quest Diagnostics  ( NYSE:DGX )  Lifted to Buy at StockNews.com,https://www.etfdailynews.com/2023/01/11/quest-diagnostics-nysedgx-lifted-to-buy-at-stocknews-com/,2023-01-11 09:54:49,StockNews.com upgraded shares of Quest Diagnostics ( NYSE:DGX - Get Rating ) from a hold rating to a buy rating in a research note published on Tuesday. DGX has been the topic of several other reports.,DGX,0.790432,0.450659,Bullish
Stocks Generating Improved Relative Strength: Lab Corp. of America,https://www.investors.com/ibd-data-stories/stocks-generating-improved-relative-strength-lab-corp-of-america/,2023-01-11 08:00:00,"Lab Corp. of America ( LH ) saw a positive improvement to its Relative Strength ( RS ) Rating on Wednesday, rising from 64 to 71. X When looking for the best stocks to buy and watch, be sure to pay attention to relative price strength.",DGX,0.285526,0.0,Neutral
"Take the Zacks Approach to Beat the Market: Boeing, Halliburton, Starbucks in Focus",https://www.zacks.com/stock/news/2036606/take-the-zacks-approach-to-beat-the-market-boeing-halliburton-starbucks-in-focus,2023-01-09 12:19:00,Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.,DGX,0.088472,0.062396,Neutral
Companies In The Anatomic Pathology Equipment And Consumables Market Develop Advance Technologies To Improve Efficiency As Per The Business Research Company's Anatomic Pathology Equipment And Consumables Global Market Report 2023,https://www.benzinga.com/pressreleases/23/01/g30260143/companies-in-the-anatomic-pathology-equipment-and-consumables-market-develop-advance-technologies-,2023-01-03 16:30:00,"LONDON, Jan. 03, 2023 ( GLOBE NEWSWIRE ) -- The Business Research Company's research on the anatomic pathology equipment and consumables market forecasts increasing investment in new technologies as a key trend in the market.",DGX,0.041251,0.0,Neutral
